RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Respiratory Tract Infections
Accession: DOID:9008680
browse the term
Definition: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Synonyms: exact_synonym: Respiratory Infection, Upper; Respiratory Infections; Respiratory Tract Infection; Upper Respiratory Infections; Upper Respiratory Tract Infections
primary_id: MESH:D012141 ; RDO:0000329
G
Bdnf
brain-derived neurotrophic factor
ISO
protein:decreased expression:platelet, serum
RGD
PMID:17317133
RGD:4891069
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:19039768
RGD:4892119
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Fbln5
fibulin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12189163
NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755
G
Il13
interleukin 13
ISO
Severe Acute Respiratory Syndrome
RGD
PMID:14633438
RGD:4145665
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il16
interleukin 16
ISO
protein:increased expression:serum
RGD
PMID:14633438
RGD:4145665
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
G
Il4
interleukin 4
ISO
associated with Asthma
RGD
PMID:20573437
RGD:5128554
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6r
interleukin 6 receptor
ISO
DNA:polymorphisms:promoter, exon:-183G>A (human)
RGD
PMID:20951753
RGD:5128631
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Irf1
interferon regulatory factor 1
ISO
RGD
PMID:10497103
RGD:5128721
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irf3
interferon regulatory factor 3
ISO
RGD
PMID:17027894
RGD:5128795
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17229951
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
protein:decreased secretion:serum (human) DNA:polymorphisms:5' utr, exon:multiple (human) DNA:SNP:exon:p.G54D(rs1800450)(human)
RGD
PMID:19169708 PMID:19767106 PMID:15249448
RGD:4889453 , RGD:4889439 , RGD:8693755
NCBI chr 1:228,016,439...228,024,736
G
Mx1
MX dynamin like GTPase 1
ISO
protein:increased expression:blood (human)
RGD
PMID:25542463
RGD:126777677
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Rpgr
retinitis pigmentosa GTPase regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12920075
NCBI chr X:12,566,447...12,628,171
Ensembl chr X:12,566,645...12,747,882
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
ISO
RGD
PMID:19775370
RGD:5144114
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Tnf
tumor necrosis factor
ISO
Severe Acute Respiratory Syndrome; protein:increased expression:serum
RGD
PMID:14633438
RGD:4145665
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ccl17
C-C motif chemokine ligand 17
ISO
associated with Cystic Fibrosis
RGD
PMID:17898016
RGD:4145612
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccr1
C-C motif chemokine receptor 1
ISO
RGD
PMID:15951834
RGD:5688155
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:10946288
RGD:8661731
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cftr
CF transmembrane conductance regulator
ISO
DNA:mutations: :
RGD
PMID:11243954
RGD:4140482
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Icam1
intercellular adhesion molecule 1
ISO
RGD
PMID:7743671
RGD:8547590
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il1a
interleukin 1 alpha
ISO
RGD
PMID:8699818
RGD:7794730
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human)
RGD
PMID:11474427 PMID:16487239
RGD:4889577 , RGD:8693711
NCBI chr 1:228,016,439...228,024,736
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
associated with cystic fibrosis; DNA:polymorphisms: :DQB1*06:02, DQB1*02:01(human)
RGD
PMID:23278646
RGD:36049760
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
associated with cystic fibrosis; DNA:polymorphisms: :
RGD
PMID:23278646
RGD:36049760
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Tlr9
toll-like receptor 9
susceptibility
ISO
DNA:SNP:promoter:g.-1237T>C rs5743836 (human)
RGD
PMID:18275280 PMID:18936185
RGD:5130863 , RGD:5130858
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:8699818
RGD:7794730
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
susceptibility
ISO
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human)
RGD
PMID:20646338
RGD:5131174
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Abcb1a
ATP binding cassette subfamily B member 1A
severity
ISO
DNA:snp:exon:c.1236C>T (human)
RGD
PMID:24040855
RGD:8657076
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Ace
angiotensin I converting enzyme
no_association
ISO
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:15112973
RGD:8142345
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Bcl2
BCL2, apoptosis regulator
IEP
mRNA, protein:increased expression:nasal mucosa (rat)
RGD
PMID:15362690
RGD:11522724
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29028686
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl11
C-C motif chemokine ligand 11
treatment
IDA
RGD
PMID:23089405
RGD:7248414
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl26
C-C motif chemokine ligand 26
ISO
protein:increased expression:oronasal secretion (human)
RGD
PMID:23883806
RGD:7364793
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
G
Cd40
CD40 molecule
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cldn3
claudin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
G
Cldn7
claudin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
treatment
ISO
RGD
PMID:10436391
RGD:11344920
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:nasal mucus
RGD
PMID:21711961
RGD:5147783
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fcgr3a
Fc gamma receptor 3A
susceptibility
ISO
DNA:polymorphism:exon:p.F158V(rs396991)(human)
RGD
PMID:18199088
RGD:5508449
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
G
Hrh1
histamine receptor H 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23333628
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
G
Ifng
interferon gamma
treatment
ISO IDA
associated with Asthma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29871060 PMID:12787306 PMID:18510219
RGD:7829803 , RGD:10755770
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:23883806 PMID:23253209
RGD:7364793 , RGD:7364818
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
susceptibility no_association
ISO
DNA:polymorphism:exon:c. 2044G>A (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.R130Q (rs20541) (human) DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) DNA:SNP:promoter:-1512A>C (rs1881457) (human)
CTD OMIM RGD
PMID:17091279 PMID:22852128 PMID:12928861 PMID:23996716
RGD:4152796 , RGD:8549518 , RGD:8549516 , RGD:8549501
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
protein:increased expression:serum
RGD
PMID:21462799
RGD:8549521
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il17a
interleukin 17A
susceptibility
ISO
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:22507625 PMID:21535180
RGD:9068429 , RGD:5147409
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
severity no_association
ISO
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human)
RGD
PMID:22840759 PMID:22840759
RGD:8655914 , RGD:8655914
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:nasal mucus
RGD
PMID:7750009
RGD:7401199
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
IEP
RGD
PMID:12592663
RGD:8662963
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
treatment
ISO IEP
RGD
PMID:9893928 PMID:24620662 PMID:8908280 PMID:14653048
RGD:7829796 , RGD:11522769 , RGD:7829827 , RGD:7829802
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
treatment
IEP
RGD
PMID:23934070 PMID:24620662
RGD:11354976 , RGD:11522769
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Itgb2
integrin subunit beta 2
treatment
IEP
RGD
PMID:12046991
RGD:9698435
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Muc1
mucin 1, cell surface associated
severity
ISO IMP IEP
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:31425778 PMID:31425778 PMID:31425778
RGD:127345100 , RGD:127345100 , RGD:127345100
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Muc1em1Cgen
mucin 1, cell surface associated; TALEN induced mutant 1, Cgen
severity
IMP
RGD
PMID:31425778
RGD:127345100
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
IEP
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:22972875
RGD:7364746
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:23858718
RGD:8547523
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Ocln
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Pon1
paraoxonase 1
severity
ISO
protein:decreased activity:plasma (human)
RGD
PMID:23406590
RGD:8547583
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Prkg1
protein kinase cGMP-dependent 1
IEP
protein:increased expression:nasal cavity epithelium
RGD
PMID:24012634
RGD:7775060
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16979129
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
ISO
RGD
PMID:20487636
RGD:5144132
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Scgb1a1
secretoglobin family 1A member 1
ISO
mRNA:decreased expression:nasal mucosa, lung
RGD
PMID:17882576
RGD:5144135
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
G
Scgb3a2
secretoglobin, family 3A, member 2
susceptibility
ISO
DNA:SNP: :rs7726552 (human)
RGD
PMID:21410962
RGD:5144225
NCBI chr18:35,932,840...35,935,762
Ensembl chr18:35,932,840...35,935,762
G
Serpine1
serpin family E member 1
ISO
mRNA:increased expression:nasal mucosa (mouse)
RGD
PMID:21339035
RGD:8547809
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Tacr1
tachykinin receptor 1
IEP
mRNA:increased expression:nasal mucosa
RGD
PMID:12768696
RGD:5147835
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:31368266
RGD:14995445
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
severity
ISO
DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa:
RGD
PMID:22402138 PMID:22555057 PMID:18381801 PMID:18219831
RGD:7800732 , RGD:8552993 , RGD:8552972 , RGD:7800742
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
severity treatment susceptibility no_association
ISO
DNA:polymorphism:cds:p.D299G(human) protein:increased expression:nasal lavage,leukocyte, bone marrow: protein:decreased expression:nasal mucosa: DNA:SNP: :rs1927911(human) DNA:polymorphism: :4216G>C(human)
RGD
PMID:22402138 PMID:22555057 PMID:22577387 PMID:17069098 PMID:23639307 PMID:19763595 More...
RGD:7800732 , RGD:8552993 , RGD:7800740 , RGD:7800738 , RGD:7800736 , RGD:4145354
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr9
toll-like receptor 9
ISO
protein:decreased expression:nasal mucosa:
RGD
PMID:22577387
RGD:7800740
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
treatment
ISO
associated with Eosinophilic Esophagitis; DNA:polymorphisms::
RGD
PMID:26416193
RGD:11352743
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Il3
interleukin 3
susceptibility
ISO
DNA:SNP: :rs40401(human)
RGD
PMID:23953855
RGD:13506915
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Ager
advanced glycosylation end product-specific receptor
ISO
DNA:SNP:promoter:-374T>A (human)
RGD
PMID:22114731
RGD:8695981
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Ccl19
C-C motif chemokine ligand 19
ISO
associated with Neutropenia;mRNA:increased expression:lung
RGD
PMID:19783686
RGD:5130908
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccr7
C-C motif chemokine receptor 7
ISO
associated with Neutropenia
RGD
PMID:19783686
RGD:5130908
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Cd209d
CD209d molecule
ISO
RGD
PMID:21381282
RGD:5131183
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
G
Cftr
CF transmembrane conductance regulator
severity
ISO
RGD
PMID:22135344
RGD:35673332
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Clec1a
C-type lectin domain family 1, member A
susceptibility
ISO
ClinVar Annotator: match by term: Aspergillosis, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:29489751
NCBI chr 4:162,875,360...162,902,571
Ensembl chr 4:162,877,346...162,901,247
G
Clec7a
C-type lectin domain containing 7A
susceptibility
ISO
ClinVar Annotator: match by term: Aspergillosis, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
G
Crp
C-reactive protein
treatment
ISO
RGD
PMID:20879853
RGD:9495929
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Il15
interleukin 15
ISO
DNA:polymorphism (human)
RGD
PMID:16893395
RGD:4981337
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Mbl1
mannose binding lectin 1
susceptibility
ISO
RGD
PMID:20064561
RGD:8694071
NCBI chr16:17,029,146...17,035,187
Ensembl chr16:17,029,118...17,035,174
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
RGD
PMID:20064561
RGD:8694071
NCBI chr 1:228,016,439...228,024,736
G
S100b
S100 calcium binding protein B
ISO
DNA:SNP: :427C>T (human)
RGD
PMID:22114731
RGD:8695981
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Tlr1
toll-like receptor 1
susceptibility
ISO
DNA:SNPs: :p.R80T, p.N248S (human)
RGD
PMID:16461792
RGD:4889535
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr2
toll-like receptor 2
ISO
mRNA:increased expression:lung
RGD
PMID:19781388
RGD:4145322
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr6
toll-like receptor 6
susceptibility
ISO
DNA:SNP: :p.S249P (human)
RGD
PMID:16461792
RGD:4889535
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
G
Ace
angiotensin I converting enzyme
ISO
associated with Cerebrovascular Accident
RGD
PMID:14990394
RGD:4140926
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
RGD
PMID:19515386
RGD:4891456
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP
RGD
PMID:19515386
RGD:4891456
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Edn1
endothelin 1
IEP
protein:increased secretion:plasma (rat)
RGD
PMID:19262391
RGD:4145069
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Il1a
interleukin 1 alpha
IEP
protein:increased expression:Bronchoalveolar Lavage Fluid
RGD
PMID:18042282
RGD:4142854
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15607125
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Tnf
tumor necrosis factor
IEP
protein:increased expression:Bronchoalveolar Lavage Fluid
RGD
PMID:18042282
RGD:4142854
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Marco
macrophage receptor with collagenous structure
disease_progression
ISO
association with Cryptococcal neoformans infection.
RGD
PMID:28298522
RGD:41412191
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
G
Abcc1
ATP binding cassette subfamily C member 1
ISO
RGD
PMID:11238654
RGD:5128828
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Ace2
angiotensin converting enzyme 2
ISO
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse)
RGD
PMID:31645418
RGD:40818279
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Ager
advanced glycosylation end product-specific receptor
severity
ISO
RGD
PMID:21629785
RGD:6767559
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
C3
complement C3
ISO
RGD
PMID:16014897
RGD:5129508
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C3ar1
complement C3a receptor 1
ISO
RGD
PMID:16461429
RGD:5129690
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
C5
complement C5
ISO
RGD
PMID:17975174
RGD:5129707
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Cat
catalase
IDA
protein:decreased expression:lung, plasma
RGD
PMID:19842849
RGD:5130748
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl19
C-C motif chemokine ligand 19
ISO
mRNA, protein:increased expression:lung
RGD
PMID:20176793
RGD:5130918
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl2
C-C motif chemokine ligand 2
ISO
RGD
PMID:20042590
RGD:4891443
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:20483921
RGD:5130905
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:20042590
RGD:4891443
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr7
C-C motif chemokine receptor 7
ISO
RGD
PMID:20176793
RGD:5130918
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Cd14
CD14 molecule
ISO
RGD
PMID:16210672
RGD:4144197
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd40
CD40 molecule
ISO
RGD
PMID:20102413
RGD:5132268
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd80
Cd80 molecule
ISO
RGD
PMID:20949109
RGD:4892562
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
ISO
RGD
PMID:18643924
RGD:5133701
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
G
Csf3
colony stimulating factor 3
disease_progression treatment
ISO
associated with Peritonitis;
RGD
PMID:21373266 PMID:12352049
RGD:5133733 , RGD:11039437
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csf3r
colony stimulating factor 3 receptor
disease_progression
ISO
RGD
PMID:17185469
RGD:5133739
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO IEP
RGD
PMID:21723409 PMID:11052817
RGD:5135062 , RGD:5135234
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
severity
ISO
RGD
PMID:16299319 PMID:15618188
RGD:5135458 , RGD:5135459
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
ISO
RGD
PMID:15618188
RGD:5135459
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl2
C-X-C motif chemokine ligand 2
severity
ISO IEP
RGD
PMID:19239431 PMID:11052817 PMID:21723409
RGD:5135065 , RGD:5135234 , RGD:5135062
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
IEP
RGD
PMID:11052817
RGD:5135234
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
RGD
PMID:19846873
RGD:4145490
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:15618188
RGD:5135459
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:15618188
RGD:5135459
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
IEP
protein:decreased expression:lung
RGD
PMID:14766666
RGD:1625385
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
G
Defb4
defensin beta 4
ISO
protein:increased expression:plasma
RGD
PMID:10213993
RGD:4892266
NCBI chr16:70,650,472...70,653,665
Ensembl chr16:70,650,472...70,653,665
G
Defb5
defensin beta 5
ISO
protein:increased expression:plasma
RGD
PMID:10213993
RGD:4892266
NCBI chr16:70,612,985...70,615,389
Ensembl chr16:70,613,146...70,615,467
G
F2
coagulation factor II, thrombin
IEP
protein:increased expression:lung
RGD
PMID:21897338
RGD:6893486
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fcgr2a
Fc gamma receptor 2A
ISO
RGD
PMID:17975174
RGD:5129707
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Foxp3
forkhead box P3
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gp1ba
glycoprotein Ib platelet subunit alpha
exacerbates
ISO
associated with Escherichia Coli Infections
RGD
PMID:27845343
RGD:42722624
NCBI chr10:55,352,938...55,355,804
Ensembl chr10:55,352,899...55,356,774
G
Grk2
G protein-coupled receptor kinase 2
ISO
mRNA:decreased expression:polymorphonuclear leukocyte
RGD
PMID:24465168
RGD:126848796
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung (mouse)
RGD
PMID:19846873
RGD:4145490
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifnar1
interferon alpha and beta receptor subunit 1
severity
ISO
RGD
PMID:19487810 PMID:19487810
RGD:5490274 , RGD:5490274
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
G
Ifng
interferon gamma
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il15
interleukin 15
ISO
RGD
PMID:17911627
RGD:5000754
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17a
interleukin 17A
severity
ISO
RGD
PMID:18802100 PMID:25398094
RGD:4889153 , RGD:38501102
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO
RGD
PMID:17664259
RGD:4889913
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
severity treatment
ISO
associated with Agranulocytosis
RGD
PMID:18596024 PMID:25398094 PMID:7546648
RGD:4143205 , RGD:38501102 , RGD:10755357
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
treatment
ISO IEP
associated with Sepsis associated with Acinetobacter infectious disease
RGD
PMID:20959556 PMID:29508184
RGD:5144223 , RGD:40818077
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il1rn
interleukin 1 receptor antagonist
ISO
RGD
PMID:18596024 PMID:18322242
RGD:4143205 , RGD:4143206
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il22
interleukin 22
ISO
RGD
PMID:21178015
RGD:5147404
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Il6
interleukin 6
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irak3
interleukin-1 receptor-associated kinase 3
ISO
RGD
PMID:28120642 PMID:20439918
RGD:34888234 , RGD:36049799
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Irf1
interferon regulatory factor 1
ISO
RGD
PMID:11854220
RGD:5128725
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irf3
interferon regulatory factor 3
ISO
RGD
PMID:20720199
RGD:4891951
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
G
Itgb3
integrin subunit beta 3
IEP
protein:increased expression:lung, neutrophil
RGD
PMID:15114484
RGD:4993468
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Lep
leptin
ISO
RGD
PMID:11937559
RGD:5128871
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Mapk8
mitogen-activated protein kinase 8
severity
ISO
associated with Escherichia Coli Infections
RGD
PMID:22514650
RGD:150340681
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mbl2
mannose binding lectin 2
ISO
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human)
RGD
PMID:18641104
RGD:4889477
NCBI chr 1:228,016,439...228,024,736
G
Mc1r
melanocortin 1 receptor
ISO
RGD
PMID:18304533
RGD:5687324
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:bronchoalveolar lavage fluid
RGD
PMID:17202364 PMID:19535150
RGD:5130727 , RGD:5129533
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
protein:increased activity:bronchoalveolar lavage Fluid:
RGD
PMID:11269653
RGD:5130992
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nod1
nucleotide-binding oligomerization domain containing 1
ISO
RGD
PMID:19360122
RGD:5131449
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
RGD
PMID:19360122
RGD:5131449
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Pdpn
podoplanin
IEP
protein:increased expression:lung
RGD
PMID:7864138
RGD:2292375
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IEP
protein:decreased expression:lung
RGD
PMID:12524254
RGD:724645
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pgf
placental growth factor
ISO
protein:increased expression:plasma
RGD
PMID:16702604
RGD:6483601
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Pten
phosphatase and tensin homolog
ameliorates
ISO
myeloid knockout
RGD
PMID:21527775
RGD:127285594
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ripk3
receptor-interacting serine-threonine kinase 3
ameliorates
ISO
RGD
PMID:28387756
RGD:127229944
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Rorc
RAR-related orphan receptor C
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Serpine1
serpin family E member 1
severity
ISO
RGD
PMID:17032919
RGD:4144840
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sftpa1
surfactant protein A1
IEP
protein:increased expression:lung
RGD
PMID:12169586
RGD:4143464
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpb
surfactant protein B
ISO IEP
associated with Cystic Fibrosis;protein:increased expression:lung
RGD
PMID:15271694 PMID:12169586
RGD:4143403 , RGD:4143464
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Sftpc
surfactant protein C
ISO IEP
RGD
PMID:18566429 PMID:12169586
RGD:4144114 , RGD:4143464
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Sftpd
surfactant protein D
ISO IEP
associated with Cystic Fibrosis;protein:decreased expression:lung protein:increased expression:lung
RGD
PMID:15271694 PMID:12169586
RGD:4143403 , RGD:4143464
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Stat3
signal transducer and activator of transcription 3
ISO
RGD
PMID:18192501
RGD:6892945
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tgfb1
transforming growth factor, beta 1
severity
ISO
RGD
PMID:25398094
RGD:38501102
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
ISO IDA
RGD
PMID:18768871 PMID:19844782
RGD:4145337 , RGD:4889533
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:20650991 PMID:16210672
RGD:4144172 , RGD:4144197
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr5
toll-like receptor 5
ISO
RGD
PMID:19801452
RGD:5129503
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
G
Tlr6
toll-like receptor 6
IDA
RGD
PMID:19844782
RGD:4889533
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
G
Tlr9
toll-like receptor 9
ISO
RGD
PMID:20360853
RGD:5130719
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
disease_progression treatment severity
ISO
associated with Agranulocytosis
RGD
PMID:10650487 PMID:7546648 PMID:9310939 PMID:12958055
RGD:4143476 , RGD:10755357 , RGD:10450564 , RGD:10449451
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
protein:increased expression:serum (mouse)
RGD
PMID:19842848
RGD:5131429
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
protein:increased expression:serum (mouse)
RGD
PMID:19842848
RGD:5131429
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Trem1
triggering receptor expressed on myeloid cells 1
severity ameliorates
ISO IDA
RGD
PMID:24465168 PMID:16960786 PMID:22996209
RGD:126848796 , RGD:127229902 , RGD:126925987
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Zc3h12a
zinc finger CCCH type containing 12A
ISO
associated with Pseudomonas Infections
RGD
PMID:29695841
RGD:39938967
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Adrb2
adrenoceptor beta 2
ISO
RGD
PMID:17687719
RGD:4145098
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Ccl11
C-C motif chemokine ligand 11
severity
ISO
protein:increased expression:nasal mucus associated with Respiratory Syncytial Virus Infections
RGD
PMID:17297249 PMID:15681407
RGD:4145460 , RGD:4145415
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Cd40
CD40 molecule
ISO
RGD
PMID:19470255
RGD:5132271
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd86
CD86 molecule
ISO
protein:decreased expression:myeloid dendritic cell (mouse)
RGD
PMID:20046053
RGD:4892291
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Crp
C-reactive protein
severity
ISO
RGD
PMID:21284715
RGD:5131282
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
associated with Pneumovirus Infections
RGD
PMID:16337014
RGD:4843953
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Il17a
interleukin 17A
susceptibility
ISO
DNA:SNP:promoter:rs2275913 (human)
RGD
PMID:20437253
RGD:4889139
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:lung
RGD
PMID:8608647
RGD:4143192
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
protein:increased expression:lung
RGD
PMID:8608647
RGD:4143192
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
ISO
DNA:polymorphisms:promoter:rs885454,rs17235353, rs7115457 (human)
RGD
PMID:15709052
RGD:7349353
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Ace
angiotensin I converting enzyme
IMP
RGD
PMID:17097496
RGD:4140933
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adora2a
adenosine A2a receptor
ISO
RGD
PMID:19766783
RGD:4890362
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Ccl17
C-C motif chemokine ligand 17
ISO
RGD
PMID:18785972
RGD:4145604
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl2
C-C motif chemokine ligand 2
IMP
RGD
PMID:14611812
RGD:2307195
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl22
C-C motif chemokine ligand 22
ISO
RGD
PMID:20628341
RGD:4891471
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl5
C-C motif chemokine ligand 5
IEP IMP
mRNA:increased expression:lung (rat)
RGD
PMID:19840961 PMID:14611812
RGD:4889978 , RGD:2307195
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
IEP
protein:increased expression:bronchoalveolar Lavage fluid
RGD
PMID:22215510
RGD:6483763
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccr2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:trachea:
RGD
PMID:11518728
RGD:4145124
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd86
CD86 molecule
IMP
RGD
PMID:11266944
RGD:2307206
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Csf2
colony stimulating factor 2
IEP
associated with Respiratory Aspiration;protein:increased expression:serum
RGD
PMID:18557728
RGD:2317286
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:16709871 PMID:12097412 PMID:12097412
RGD:5135441 , RGD:5135451 , RGD:5135451
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:12097412 PMID:12097412
RGD:5135451 , RGD:5135451
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:16709871 PMID:12097412 PMID:12097412
RGD:5135441 , RGD:5135451 , RGD:5135451
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:16709871 PMID:12097412
RGD:5135441 , RGD:5135451
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Edn1
endothelin 1
ISO
human gene in a rat model
RGD
PMID:9595474
RGD:8662402
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Foxp3
forkhead box P3
IEP
mRNA:increased expression:lung
RGD
PMID:19840961
RGD:4889978
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gzmb
granzyme B
ISO
RGD
PMID:19737140
RGD:5135518
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:12973103
RGD:4145412
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16137903
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il13
interleukin 13
ISO
protein:increased expression:bronchoalveolar lavage fluid
RGD
PMID:17182591
RGD:4146242
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra1
interleukin 13 receptor subunit alpha 1
ISO
RGD
PMID:17182591
RGD:4146242
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:17182591
RGD:4146242
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il17a
interleukin 17A
ISO
mRNA:increased expression:trachea
RGD
PMID:20393404
RGD:4143277
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1rn
interleukin 1 receptor antagonist
ISO
protein:increased expression:lung
RGD
PMID:11889437
RGD:4143176
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il4
interleukin 4
IEP
protein:increased expression:serum
RGD
PMID:18557728
RGD:2317286
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
ISO
RGD
PMID:20393404
RGD:4143277
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mbl2
mannose binding lectin 2
resistance
ISO
DNA:transversion:5' utr:-290C>G rs7096206 (human)
RGD
PMID:19104434
RGD:4889456
NCBI chr 1:228,016,439...228,024,736
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression, increased activity:bronchoalveolar lavage fluid
RGD
PMID:20417130
RGD:5130759
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc1
mucin 1, cell surface associated
ISO
protein:increased expression:serum
RGD
PMID:16969297
RGD:5131273
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
RGD
PMID:18158963
RGD:5131450
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
ISO
associated with lung transplantation; protein:increased expression:lung
RGD
PMID:11112135
RGD:4892082
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
IEP
protein:increased expression:lung
RGD
PMID:15136885
RGD:4892068
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Scgb1a1
secretoglobin family 1A member 1
ISO
associated with lung transplantation; protein:decreased expression:serum,bronchoalveolar lavage
RGD
PMID:11981419
RGD:5147386
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
G
Sftpd
surfactant protein D
ISO
RGD
PMID:18347569
RGD:4143500
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Tlr9
toll-like receptor 9
ISO
DNA:SNPs:promoter, 3' utr:g.-1485C>T (rs187084), rs352162 (human)
RGD
PMID:20227302
RGD:5130722
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
DNA:polymorphism (human)
RGD
PMID:14593914
RGD:4889126
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Egr1
early growth response 1
ISO
RGD
PMID:17384085
RGD:5132266
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Hdac2
histone deacetylase 2
treatment
IEP
RGD
PMID:22708526
RGD:9590258
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Ifng
interferon gamma
resistance
ISO
RGD
PMID:20953328
RGD:4145525
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:serum (human)
RGD
PMID:20350425
RGD:4892019
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cxcr2
C-X-C motif chemokine receptor 2
disease_progression
ISO
associated with Plague
RGD
PMID:21356370
RGD:5134954
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Mbl2
mannose binding lectin 2
ISO
associated with Down Syndrome; protein:decreased secretion:serum (human)
RGD
PMID:19804807
RGD:4889483
NCBI chr 1:228,016,439...228,024,736
G
Cd274
CD274 molecule
ISO
mRNA:increased expression:lung
RGD
PMID:26378990
RGD:41412180
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Pdcd1
programmed cell death 1
ISO
mRNA:increased expression:lung
RGD
PMID:26378990
RGD:41412180
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
severity
ISO
RGD
PMID:29893841
RGD:40890270
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Ccl11
C-C motif chemokine ligand 11
ISO
RGD
PMID:11991282
RGD:4145442
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Cftr
CF transmembrane conductance regulator
susceptibility
ISO
DNA:deletion: :F508del(human) associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human)
RGD
PMID:10767489 PMID:15463907
RGD:4140484 , RGD:4140475
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:19386687
RGD:4891509
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:15928955
RGD:4142512
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
DNA:polymorphism (human)
RGD
PMID:14593914
RGD:4889126
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Edn1
endothelin 1
ISO
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse)
RGD
PMID:18631350
RGD:4145074
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Gc
GC, vitamin D binding protein
susceptibility
ISO
RGD
PMID:12096683
RGD:5129516
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gstm1
glutathione S-transferase mu 1
severity
ISO
DNA:deletion: : DNA:deletion, haplotype: : (human)
RGD
PMID:9187680 PMID:15125256
RGD:4142513 , RGD:12798508
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:15928955
RGD:4142512
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Icam1
intercellular adhesion molecule 1
IEP
protein:increased expression:bronchial epithelium (rat)
RGD
PMID:19507274
RGD:2308951
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
IEP
protein:decreased expression:lung
RGD
PMID:19507274
RGD:2308951
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
ISO
protein:increased expression:Respiratory Mucosa
RGD
PMID:14582911
RGD:4759835
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il15
interleukin 15
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11742275
RGD:4990461
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Mpo
myeloperoxidase
IEP
protein:increased expression:lung
RGD
PMID:11798689
RGD:5130990
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nos2
nitric oxide synthase 2
IDA
RGD
PMID:19938219
RGD:4891494
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9731035
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19263519
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Edn1
endothelin 1
ISO
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human)
RGD
PMID:8845175
RGD:8661738
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Cd8a
CD8 subunit alpha
ameliorates
ISO
protein:decreased expression:blood, T cell (human)
RGD
PMID:24639246
RGD:124715444
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
G
Il17a
interleukin 17A
ISO
protein:increased expression:uncinate process, nasal mucosa (human)
RGD
PMID:23613503
RGD:8696039
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human)
RGD
PMID:16549749
RGD:8549791
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Mbl2
mannose binding lectin 2
ISO
protein:decreased activity:serum:
RGD
PMID:23144819
RGD:8693716
NCBI chr 1:228,016,439...228,024,736
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
disease_progression
ISO
associated with Nasal Polyps;
RGD
PMID:24450586
RGD:13506943
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
G
Alox5
arachidonate 5-lipoxygenase
ISO
protein:increased expression:bronchus
RGD
PMID:11865407
RGD:4890421
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
protein:increased expression:bronchus
RGD
PMID:11865407
RGD:4890421
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:20696083
RGD:4140458
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell
RGD
PMID:20395558
RGD:4145446
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:15764644
RGD:5135489
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell
RGD
PMID:20395558
RGD:4145446
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
associated with Asthma
RGD
PMID:12751040
RGD:5135264
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:19864593
RGD:5131210
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Defb4
defensin beta 4
ISO
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus
RGD
PMID:15034083
RGD:4892264
NCBI chr16:70,650,472...70,653,665
Ensembl chr16:70,650,472...70,653,665
G
Defb5
defensin beta 5
ISO
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus
RGD
PMID:15034083
RGD:4892264
NCBI chr16:70,612,985...70,615,389
Ensembl chr16:70,613,146...70,615,467
G
Ifna2
interferon alpha 2
treatment
ISO
RGD
PMID:6381610
RGD:40886344
NCBI chr 5:103,258,617...103,259,195
G
Il10
interleukin 10
ISO
RGD
PMID:20696083
RGD:4140458
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1a
interleukin 1 alpha
ISO
protein:increased expression:nasal mucus
RGD
PMID:10358201
RGD:4143183
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:nasal mucus
RGD
PMID:7734976
RGD:7401200
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
protein:increased expression:nasal mucus
RGD
PMID:18279051 PMID:10358201
RGD:4143207 , RGD:4143183
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il33
interleukin 33
ISO
protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
ISO
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion
RGD
PMID:20644177
RGD:4140459
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Prdx5
peroxiredoxin 5
ISO
associated with asthma;protein:increased expression:sputum (human)
RGD
PMID:18219526
RGD:41404684
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
G
Tslp
thymic stromal lymphopoietin
ISO
protein:increased expression:nasal mucus (human)
RGD
PMID:28471975
RGD:38596342
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
protein:increased expression:lung, macrophage (human)
RGD
PMID:21144722
RGD:5131112
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
protein:increased expression:lung, lymphocyte (human)
RGD
PMID:21144722
RGD:5131112
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Sftpc
surfactant protein C
ISS
OMIM:263000
MouseDO
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:SNP:exon:p.G54D(rs1800450)(human)
RGD
PMID:15249448
RGD:8693755
NCBI chr 1:228,016,439...228,024,736
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
ISO
protein:decreased expression:bronchiole epithelium
RGD
PMID:15364771
RGD:7364741
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
ISO
DNA:insertion/deletion
RGD
PMID:15709052
RGD:7349353
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Mucl3
mucin like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22152429
NCBI chr20:3,100,652...3,108,569
Ensembl chr20:3,100,679...3,108,569
G
Tap2
transporter 2, ATP binding cassette subfamily B member
susceptibility
ISO
DNA:polymorphisms:exon:
RGD
PMID:10323341
RGD:5147847
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Ccl7
C-C motif chemokine ligand 7
ISO
protein:increased expression:ethmoid sinus
RGD
PMID:9800627
RGD:6483785
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
C5
complement C5
ISO
RGD
PMID:2612053
RGD:5130160
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Ccl7
C-C motif chemokine ligand 7
ISO
RGD
PMID:20045013
RGD:5129686
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Gata2
GATA binding protein 2
IEP
associated with Pneumocystis Infections
RGD
PMID:16774119
RGD:9587813
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
G
Il13
interleukin 13
IEP ISO
protein:increased expression:lung
RGD
PMID:16544260 PMID:19752036
RGD:4145506 , RGD:4145474
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il33
interleukin 33
ISO
protein:increased expression:lung
RGD
PMID:25746970
RGD:39938968
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Nos2
nitric oxide synthase 2
IEP
protein:decreased expression:lung
RGD
PMID:10639453
RGD:4891455
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Sftpa1
surfactant protein A1
susceptibility
ISO
RGD
PMID:20413160
RGD:4143489
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpd
surfactant protein D
susceptibility
ISO
RGD
PMID:20413160 PMID:20413160
RGD:4143489 , RGD:4143489
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Tnf
tumor necrosis factor
IEP
protein:increased expression:lung
RGD
PMID:16544260
RGD:4145506
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
susceptibility
ISO
DNA:polymorphism:cds:allele AB (human)
RGD
PMID:6189297 PMID:4375858
RGD:5128836 , RGD:39938844
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
G
Atf3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
C3
complement C3
ISO
RGD
PMID:21408070
RGD:5129492
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp1
caspase 1
ISO
RGD
PMID:19362023
RGD:5130181
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Cat
catalase
ISO
RGD
PMID:16804020 PMID:20653246 PMID:19959187
RGD:5130864 , RGD:5130201 , RGD:5130744
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl11
C-C motif chemokine ligand 11
ISO
associated with Asthma;protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20656925 PMID:12707338
RGD:4145452 , RGD:4145439
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
ISO
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23326326 PMID:20967263
RGD:4891425
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl28
C-C motif chemokine ligand 28
resistance
ISO
RGD
PMID:19847203
RGD:4892196
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
G
Ccl5
C-C motif chemokine ligand 5
susceptibility
ISO
protein:increased expression:lung (mouse)
RGD
PMID:20656925 PMID:16208318
RGD:4145452 , RGD:4892131
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr5
C-C motif chemokine receptor 5
severity
ISO
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:19039768 PMID:18617426 PMID:20875295
RGD:4892119 , RGD:4892122 , RGD:4892063
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd14
CD14 molecule
ISO
RGD
PMID:17825924
RGD:4144809
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd209c
CD209c molecule
susceptibility
ISO
RGD
PMID:21191006
RGD:5131189
NCBI chr12:1,936,233...1,943,841
Ensembl chr12:1,936,396...1,942,040
G
Cd209d
CD209d molecule
susceptibility
ISO
RGD
PMID:21191006
RGD:5131189
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
G
Cd28
Cd28 molecule
ISO
RGD
PMID:21389258
RGD:5131611
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd40
CD40 molecule
ISO
RGD
PMID:19922665
RGD:5132270
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd80
Cd80 molecule
ISO
RGD
PMID:19922665 PMID:10604996
RGD:5132270 , RGD:5132623
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd86
CD86 molecule
ISO
protein:increased expression:mediastinal lymph node, B cell (mouse)
RGD
PMID:19933871
RGD:4892570
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Crp
C-reactive protein
ISO
protein:increased expression:serum
RGD
PMID:21509252
RGD:5131277
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf2
colony stimulating factor 2
ISO
RGD
PMID:20427198 PMID:21474645
RGD:5131472 , RGD:5131470
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:respiratory system fluid/secretion protein:increased expression:lung, serum
RGD
PMID:20656925 PMID:17348295
RGD:4145452 , RGD:4145366
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
mRNA:increased expression:lung
RGD
PMID:21251691 PMID:20967263
RGD:5135026 , RGD:4891425
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Ddx60
DEXD/H-box helicase 60
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Egr1
early growth response 1
ISO
mRNA:increased expression:frontal cortex (mouse)
RGD
PMID:21289196
RGD:5131660
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Foxp2
forkhead box P2
ISO
RGD
PMID:18248790
RGD:11536002
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
G
Gbp1
guanylate binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Herc6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
G
Ifi27
interferon, alpha-inducible protein 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifi35
interferon-induced protein 35
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifi44
interferon-induced protein 44
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifih1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm3
interferon induced transmembrane protein 3
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Influenza, severe, susceptibility to
CTD ClinVar OMIM
PMID:20943977 PMID:22446628 PMID:23326326
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Il10
interleukin 10
susceptibility
ISO
RGD
PMID:20200252
RGD:4140426
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ISO
RGD
PMID:16389596
RGD:4145426
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il13
interleukin 13
ISO
protein:increased expression:serum
RGD
PMID:20003352
RGD:4888530
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il15
interleukin 15
ISO
mRNA, protein:increased expression:lung
RGD
PMID:20212069 PMID:19234203 PMID:21098221
RGD:4996471 , RGD:4996472 , RGD:4994196
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il15ra
interleukin 15 receptor subunit alpha
ISO
RGD
PMID:21098221
RGD:4994196
NCBI chr17:66,802,300...66,831,973
Ensembl chr17:66,802,334...66,832,278
G
Il17a
interleukin 17A
ISO
mRNA, protein:increased expression:lung
RGD
PMID:19783685 PMID:19265125
RGD:4889102 , RGD:4889150
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il17ra
interleukin 17 receptor A
ISO
RGD
PMID:19783685
RGD:4889102
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
G
Il18
interleukin 18
ISO
RGD
PMID:15606801
RGD:4889964
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
protein:increased expression:lung
RGD
PMID:11535264
RGD:4142860
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:20438620
RGD:4142822
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
disease_progression
ISO
protein:increased expression:serum
RGD
PMID:9439800 PMID:20840779
RGD:4143228 , RGD:4143203
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
ISO
protein:increased expression:serum
RGD
PMID:21603856
RGD:5147905
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il22
interleukin 22
ISO
RGD
PMID:21178015 PMID:20504940
RGD:5147404 , RGD:5147405
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Il4
interleukin 4
ISO
RGD
PMID:21092162
RGD:5128546
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
ISO
RGD
PMID:20731583
RGD:4143268
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf7
interferon regulatory factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Isg15
ISG15 ubiquitin-like modifier
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Lamp3
lysosomal-associated membrane protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
G
Ly6e
lymphocyte antigen 6 family member E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
G
Lyst
lysosomal trafficking regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26597256
NCBI chr17:86,241,384...86,443,501
Ensembl chr17:86,241,384...86,443,480
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased activity:lung, heart, brain
RGD
PMID:20299740
RGD:5130855
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mx1
MX dynamin like GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Mx2
MX dynamin like GTPase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342
G
Nos1
nitric oxide synthase 1
ISO
protein:increased expression:hippocampus
RGD
PMID:9552178
RGD:5132870
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
ISO
mRNA:increased expression:olfactory epithelium mRNA,protein:increased expression:brain
RGD
PMID:17674769 PMID:18080188 PMID:17030871
RGD:4891919 , RGD:4891937 , RGD:4891952
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Oas1a
2'-5' oligoadenylate synthetase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
G
Oas2
2'-5' oligoadenylate synthetase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:35,802,824...35,830,778
Ensembl chr12:35,806,759...35,829,371
G
Oas3
2'-5'-oligoadenylate synthetase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
G
Oasl
2'-5'-oligoadenylate synthetase-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Parp12
poly (ADP-ribose) polymerase family, member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
G
Plscr1
phospholipid scramblase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
G
Prf1
perforin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26597256
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:16272346
RGD:5143925
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rig1
RNA sensor RIG-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Rsad2
radical S-adenosyl methionine domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
RT1-Db1
RT1 class II, locus Db1
ISO
RGD
PMID:19386707
RGD:4144816
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
ISO
RGD
PMID:21087648
RGD:5144131
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Rtp4
receptor (chemosensory) transporter protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
G
Samd9
sterile alpha motif domain containing 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 4:31,164,639...31,184,278
Ensembl chr 4:31,164,510...31,184,322
G
Serping1
serpin family G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sftpd
surfactant protein D
IMP
RGD
PMID:16787926
RGD:4143518
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Siglec1
sialic acid binding Ig like lectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:118,287,988...118,307,125
Ensembl chr 3:118,287,988...118,306,850
G
Slc22a8
solute carrier family 22 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23129053
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Stat1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Tdrd7
tudor domain containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544
G
Tlr2
toll-like receptor 2
ISO
protein:increased expression:monocyte
RGD
PMID:18657324
RGD:4145339
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:16789835 PMID:18654661
RGD:5129219 , RGD:5129136
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tmprss11d
transmembrane serine protease 11D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20237084 PMID:23072892
NCBI chr14:21,707,336...21,769,398
Ensembl chr14:21,707,336...21,769,396
G
Tmprss4
transmembrane serine protease 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26889029
NCBI chr 8:45,475,819...45,508,409
Ensembl chr 8:45,476,053...45,508,409
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:serum
RGD
PMID:21062445
RGD:5128683
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
protein:increased expression:serum (human)
RGD
PMID:17182684 PMID:19497758
RGD:5131157 , RGD:5131432
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tor1b
torsin family 1, member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:14,243,181...14,249,279
Ensembl chr 3:14,243,243...14,249,272
G
Trex1
three prime repair exonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ugcg
UDP-glucose ceramide glucosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33639165
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Xaf1
XIAP associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Xist
X inactive specific transcript
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr X:68,474,987...68,492,500
G
Zcchc2
zinc finger CCHC-type containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326326
NCBI chr13:22,118,677...22,193,626
Ensembl chr13:22,119,568...22,166,373
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
associated with Scleroderma, Diffuse protein:increased expression:serum
RGD
PMID:18432520 PMID:16085216
RGD:5135258 , RGD:5135260
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung, alveolar macrophage (human)
RGD
PMID:19218648
RGD:4145518
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il6
interleukin 6
IEP
protein:increased expression:bronchoalveolar lavage (rat)
RGD
PMID:10988147
RGD:11062092
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Keap1
Kelch-like ECH-associated protein 1
ISO
protein:increased expression:hyperplastic lung epithelium, alveolus (human)
RGD
PMID:20718723
RGD:6893300
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Mtor
mechanistic target of rapamycin kinase
ISO
RGD
PMID:21444868
RGD:7245946
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Scgb1a1
secretoglobin family 1A member 1
ISO
protein:increased expression:serum
RGD
PMID:15467329
RGD:5144148
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
G
Abca3
ATP binding cassette subfamily A member 3
ISO
ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:15976379 PMID:17597647 PMID:18024538 PMID:18246475 PMID:18317237 PMID:18603241 PMID:18676873 PMID:22145626 PMID:22304854 PMID:22434821 PMID:22435821 PMID:22800827 PMID:22866751 PMID:23166334 PMID:23625987 PMID:24033266 PMID:24136335 PMID:24871971 PMID:25073622 PMID:25553246 PMID:25741868 PMID:27374344 PMID:27516224 PMID:28034695 PMID:28492532 PMID:28642621 PMID:29431110 PMID:29505158 PMID:29566461 PMID:30609409 PMID:30755392 PMID:31589614 PMID:31980526 PMID:32238781 PMID:32532878 PMID:32692933 PMID:33110422 PMID:33526094 PMID:34132118 PMID:34715861 PMID:35170262 PMID:35626240 More...
NCBI chr10:13,382,439...13,439,748
Ensembl chr10:13,382,540...13,439,745
G
Ahrr
aryl-hydrocarbon receptor repressor
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
G
Akt1
AKT serine/threonine kinase 1
ISO
mRNA:increased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Apoa1
apolipoprotein A1
ISO
protein: decreased expression: respiratory system fluid/secretion
RGD
PMID:20463180
RGD:5508222
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Atp11a
ATPase phospholipid transporting 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23583980
NCBI chr16:76,657,752...76,767,640
Ensembl chr16:76,657,752...76,767,640
G
Bmp1
bone morphogenetic protein 1
ISO
ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
G
Brd4
bromodomain containing 4
ISO
RGD
PMID:23759512
RGD:9586353
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
G
Brd9
bromodomain containing 9
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,329,981...29,357,285
Ensembl chr 1:29,329,985...29,357,016
G
Ccl12
C-C motif chemokine ligand 12
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28434932
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
G
Cep72
centrosomal protein 72
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,225,312...29,255,294
Ensembl chr 1:29,225,361...29,255,271
G
Cflar
CASP8 and FADD-like apoptosis regulator
ISO
mRNA,protein:increased expression:lung myofibroblast:
RGD
PMID:22582174
RGD:11341695
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Ctc1
CST telomere replication complex component 1
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr10:53,714,614...53,735,298
Ensembl chr10:53,714,644...53,735,298
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
DNA:polymorphism:promoter:-156G>C (human) protein:increased expression:lung, macrophage, type II pneumocyte
RGD
PMID:20137269 PMID:11751193
RGD:5135241 , RGD:5135250
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Ddr1
discoidin domain receptor tyrosine kinase 1
treatment
ISO IMP
mRNA:increased expression:lung (human)
RGD
PMID:30119248 PMID:30119248
RGD:151347411 , RGD:151347411
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Dpp9
dipeptidyl peptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23583980
NCBI chr 9:1,011,347...1,046,337
Ensembl chr 9:1,011,351...1,046,541
G
Dsp
desmoplakin
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Interstitial lung disease 2
CTD ClinVar
PMID:23583980
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
G
Dtnbp1
dystrobrevin binding protein 1
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr17:19,685,218...19,776,668
Ensembl chr17:19,685,215...19,776,661
G
Ehmt2
euchromatic histone lysine methyltransferase 2
ISO
RGD
PMID:24652950
RGD:9589169
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
G
Ep300
E1A binding protein p300
treatment
ISO IMP
mRNA:increased expression:lung (human)
RGD
PMID:30119248 PMID:30119248
RGD:151347411 , RGD:151347411
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30165855
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Exoc3
exocyst complex component 3
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045
G
F3
coagulation factor III, tissue factor
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:10946084
RGD:11060143
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fam13a
family with sequence similarity 13, member A
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Interstitial lung disease 2
CTD ClinVar
PMID:23583980
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:15148335
RGD:11049166
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
ISO
RGD
PMID:15148335
RGD:11049166
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fgfr2
fibroblast growth factor receptor 2
ISO
protein:increased expression:lung (human)
RGD
PMID:29722558
RGD:155791445
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Gper1
G protein-coupled estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30165855
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28434932
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hps4
HPS4, biogenesis of lysosomal organelles complex 3 subunit 2
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr12:44,264,037...44,294,791
Ensembl chr12:44,264,037...44,294,632
G
Il1rl1
interleukin 1 receptor-like 1
ISO
protein:increased expression:serum
RGD
PMID:14555548
RGD:5144236
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il1rn
interleukin 1 receptor antagonist
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:16199547 PMID:19494218 PMID:21792839 PMID:22940634 PMID:26100510 PMID:28492532 More...
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:21309737
RGD:5147438
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Lama3
laminin subunit alpha 3
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
G
Mir184
microRNA 184
ISO
RNA:decreased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
G
Mir31
microRNA 31
ISO
RNA:increased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr 5:103,599,038...103,599,143
G
Mmp1
matrix metallopeptidase 1
ISO
protein:increased expression:lung,bronchoalveolar lavage fluid: ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar RGD
PMID:18447576
RGD:4890373
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp19
matrix metallopeptidase 19
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr 7:1,221,229...1,229,555
Ensembl chr 7:1,221,343...1,229,555
G
Mmp3
matrix metallopeptidase 3
ISO
mRNA, protein:increased expression:lung CTD Direct Evidence: therapeutic
CTD RGD
PMID:28434932 PMID:21871427
RGD:8694097
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Muc1
mucin 1, cell surface associated
ISO
protein:increased expression:serum:
RGD
PMID:22963039
RGD:7244290
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
CTD OMIM ClinVar
PMID:21506741 PMID:21506748 PMID:23321605 PMID:23583980 PMID:23692170 PMID:23695349 PMID:23940607 PMID:24033266 PMID:25741868 PMID:25926289 PMID:28492532 PMID:30345907 More...
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Nkd2
NKD inhibitor of WNT signaling pathway 2
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,442,898...29,470,839
Ensembl chr 1:29,441,328...29,470,821
G
Nkx2-1
NK2 homeobox 1
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:lung
RGD
PMID:21330466
RGD:5684550
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Parn
poly(A)-specific ribonuclease
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25848748
NCBI chr10:1,410,636...1,548,573
Ensembl chr10:1,410,642...1,548,560
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
mRNA,protein:increased expression, increased activity:fibroblast
RGD
PMID:23260200
RGD:10413908
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdcd6
programmed cell death 6
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:28,966,518...28,982,188
Ensembl chr 1:28,966,518...28,982,189
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18491991
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
DNA:SNPs: :3050G>C, 8473C>T (human) protein:decreased expression:lung:
RGD
PMID:21319594 PMID:14511257 PMID:20203246
RGD:5135280 , RGD:5135507 , RGD:5135461
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:21373184
RGD:5147566
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Rtel1
regulator of telomere elongation helicase 1
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
CTD ClinVar
PMID:16199547 PMID:23329068 PMID:23453664 PMID:23959892 PMID:24009516 PMID:24033266 PMID:25047097 PMID:25099625 PMID:25607374 PMID:25620558 PMID:25741868 PMID:25848748 PMID:26025130 PMID:28099038 PMID:28492532 PMID:29344583 PMID:36655009 PMID:37392813 More...
NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348
G
Rtkn2
rhotekin 2
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr20:20,536,628...20,609,951
Ensembl chr20:20,525,256...20,609,951
G
Sdha
succinate dehydrogenase complex flavoprotein subunit A
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
G
Setd2
SET domain containing 2, histone lysine methyltransferase
exacerbates
ISO
associated with lung squamous cell carcinoma; DNA:mutations:multiple (human)
RGD
PMID:33533494
RGD:150429642
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Sftpa1
surfactant protein A1
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2 | ClinVar Annotator: match by term: Pulmonary fibrosis, idiopathic, susceptibility to
ClinVar
PMID:13680361 PMID:24033266 PMID:25741868
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpc
surfactant protein C
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Interstitial lung disease 2
CTD ClinVar
PMID:14735158 PMID:15039969 PMID:15516475 PMID:15709974 PMID:18383112 PMID:19443464 PMID:19910179 PMID:22308375 PMID:23025826 PMID:23775869 PMID:24033266 PMID:24081995 PMID:24347114 PMID:25657025 PMID:25741868 PMID:25782673 PMID:27362365 PMID:28492532 PMID:33526882 More...
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Slc12a7
solute carrier family 12 member 7
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,472,692...29,554,246
Ensembl chr 1:29,472,692...29,554,302
G
Slc6a18
solute carrier family 6 member 18
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925
G
Slc6a19
solute carrier family 6 member 19
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,586,191...29,604,964
Ensembl chr 1:29,586,195...29,604,962
G
Slc9a3
solute carrier family 9 member A3
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417
G
Smad2
SMAD family member 2
ISO
mRNA:increased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smad6
SMAD family member 6
ISO
mRNA:decreased expression:blood plasma (human)
RGD
PMID:31874165
RGD:152995482
NCBI chr 8:64,450,114...64,519,673
Ensembl chr 8:64,450,114...64,519,763
G
St14
ST14 transmembrane serine protease matriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26599507
NCBI chr 8:29,540,805...29,581,704
Ensembl chr 8:29,540,811...29,581,517
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30481203 PMID:22684844
RGD:6892915
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stn1
STN1 subunit of CST complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23583980
NCBI chr 1:246,391,311...246,429,844
Ensembl chr 1:246,395,613...246,429,531
G
Terc
telomerase RNA component
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2 CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:17392301 PMID:17460043 PMID:23535734
NCBI chr 2:112,815,654...112,816,041
G
Tert
telomerase reverse transcriptase
ISO
DNA:deletion, missense mutations, splice-site mutations:multiple ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis | ClinVar Annotator: match by term: Idiopathic fibrosing alveolitis, chronic form | ClinVar Annotator: match by term: Interstitial lung disease 2 ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis | ClinVar Annotator: match by term: Interstitial lung disease 2 ClinVar Annotator: match by term: Familial idiopathic pulmonary fibrosis | ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis | ClinVar Annotator: match by term: Idiopathic fibrosing alveolitis, chronic form ClinVar Annotator: match by term: Fibrocystic pulmonary dysplasia | ClinVar Annotator: match by term: Idiopathic Pulmonary Fibrosis | ClinVar Annotator: match by term: Idiopathic fibrosing alveolitis, chronic form CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:2602487 PMID:9536098 PMID:12629597 PMID:15814878 PMID:15885610 PMID:16199547 PMID:16247010 PMID:16332973 PMID:16627250 PMID:16990594 PMID:17264120 PMID:17392301 PMID:17460043 PMID:17576681 PMID:17785587 PMID:18042801 PMID:18302718 PMID:18460650 PMID:18635888 PMID:18753630 PMID:18931339 PMID:19147845 PMID:19489057 PMID:19561322 PMID:19674077 PMID:19760749 PMID:19796246 PMID:20022961 PMID:20044353 PMID:20301779 PMID:20502709 PMID:20858879 PMID:20871597 PMID:20966039 PMID:21258621 PMID:21436073 PMID:21483807 PMID:21520173 PMID:21520174 PMID:21543794 PMID:21602826 PMID:21635204 PMID:21931702 PMID:22037553 PMID:22364217 PMID:22424236 PMID:22476886 PMID:22512499 PMID:22664374 PMID:22853774 PMID:22863003 PMID:23066086 PMID:23258901 PMID:23335200 PMID:23348503 PMID:23535731 PMID:23535734 PMID:23538340 PMID:23583980 PMID:23716176 PMID:23901009 PMID:23905534 PMID:24033266 PMID:24833766 PMID:24983628 PMID:25108601 PMID:25271372 PMID:25346280 PMID:25365545 PMID:25393420 PMID:25562321 PMID:25612863 PMID:25640679 PMID:25741868 PMID:25785092 PMID:26024875 PMID:26136524 PMID:26158642 PMID:26194807 PMID:26329388 PMID:26365799 PMID:26433962 PMID:26580448 PMID:26887940 PMID:27159321 PMID:27192671 PMID:27354474 PMID:27418648 PMID:27540018 PMID:27622320 PMID:27836952 PMID:27848944 PMID:27854218 PMID:28099038 PMID:28102861 PMID:28104920 PMID:28154186 PMID:28192371 PMID:28492532 PMID:28495683 PMID:28495692 PMID:28677271 PMID:28813500 PMID:28818973 PMID:28873162 PMID:29036293 PMID:29382801 PMID:29463756 PMID:29483670 PMID:29625052 PMID:29749397 PMID:30203795 PMID:30426156 PMID:30523342 PMID:30603600 PMID:30791107 PMID:30995915 PMID:31265491 PMID:31268371 PMID:31395865 PMID:32150348 PMID:32315675 PMID:33035329 PMID:33709208 PMID:33718801 PMID:34019641 PMID:34890115 PMID:35776903 PMID:17392301 More...
RGD:11038666
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfpi
tissue factor pathway inhibitor
severity
ISO
protein:increased expression:Bronchoalveolar lavage,epithelial cell:
RGD
PMID:10946084
RGD:11060143
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Thbd
thrombomodulin
severity
ISO
RGD
PMID:20418386
RGD:5685036
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8473757
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tollip
toll interacting protein
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
NCBI chr 1:196,961,585...196,984,252
Ensembl chr 1:196,950,771...196,983,625
G
Tppp
tubulin polymerization promoting protein
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,257,111...29,281,134
Ensembl chr 1:29,261,255...29,281,134
G
Trip13
thyroid hormone receptor interactor 13
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
G
Wnt5a
Wnt family member 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28726637
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
G
Zdhhc11
zinc finger, DHHC-type containing 11
ISO
ClinVar Annotator: match by term: Interstitial lung disease 2
ClinVar
PMID:12629597 PMID:28492532
NCBI chr 1:29,296,334...29,327,227
Ensembl chr 1:29,296,334...29,326,898
G
Atm
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:31509427
RGD:126779564
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Btk
Bruton tyrosine kinase
ameliorates
ISO
Associated with Acute Lung Injury
RGD
PMID:29516781
RGD:124713566
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
G
Duox1
dual oxidase 1
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:24888898
RGD:40903071
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
G
Duox2
dual oxidase 2
severity
ISO
RGD
PMID:28936773 PMID:25751630 PMID:29556357
RGD:40924644 , RGD:40925925 , RGD:40925921
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Ifih1
interferon induced with helicase C domain 1
ISO
mRNA:increased expression:nasal cavity mucosa (mouse)
RGD
PMID:25751630
RGD:40925925
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Il21
interleukin 21
ISO
RGD
PMID:25251568
RGD:127285548
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il27
interleukin 27
ISO
protein:increased expression:blood serum (human)
RGD
PMID:22343630
RGD:126790513
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:26241898
RGD:11055126
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapk8
mitogen-activated protein kinase 8
ameliorates
ISO
RGD
PMID:22514650
RGD:150340681
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Marco
macrophage receptor with collagenous structure
ameliorates
ISO
RGD
PMID:21562316
RGD:41412197
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
G
Mavs
mitochondrial antiviral signaling protein
disease_progression
ISO
RGD
PMID:27438481
RGD:40903047
NCBI chr 3:118,451,650...118,466,094
Ensembl chr 3:118,451,743...118,466,094
G
Mir146a
microRNA 146a
exacerbates ameliorates
ISO
RGD
PMID:31638222 PMID:30611999
RGD:126925152 , RGD:126925153
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mx1
MX dynamin like GTPase 1
ameliorates
ISO
fused with PTD 9-arginine sequence human gene in a mouse model
RGD
PMID:30696001 PMID:31653718 PMID:1371172 PMID:30945621
RGD:126777671 , RGD:126777680 , RGD:126777676 , RGD:126777673
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Plac8
placenta associated 8
ISO
RGD
PMID:32639988
RGD:40925929
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Ppia
peptidylprolyl isomerase A
ameliorates
ISO
human gene in a mouse model
RGD
PMID:27354005
RGD:150429624
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Rig1
RNA sensor RIG-1
ISO
mRNA:increased expression:nasal cavity mucosa (mouse)
RGD
PMID:25751630
RGD:40925925
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Ripk3
receptor-interacting serine-threonine kinase 3
exacerbates susceptibility
ISO
RGD
PMID:27321907 PMID:32200799 PMID:28410401
RGD:127229911 , RGD:127229922 , RGD:127229918
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Stat2
signal transducer and activator of transcription 2
exacerbates
ISO
RGD
PMID:30337919
RGD:41789626
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
G
Ager
advanced glycosylation end product-specific receptor
ISO
RGD
PMID:21423669
RGD:5508765
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Ccl2
C-C motif chemokine ligand 2
severity
ISO
RGD
PMID:11160230
RGD:11528533
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
ISO
protein:increased expression:lung
RGD
PMID:20926800
RGD:7483599
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccr6
C-C motif chemokine receptor 6
disease_progression
ISO
RGD
PMID:17379855
RGD:7483617
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:17298426
RGD:5135501
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cybb
cytochrome b-245 beta chain
ISO
RGD
PMID:24054721
RGD:10450528
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
treatment
ISO
DNA:polymorphisms:cds:
RGD
PMID:26861072
RGD:124713410
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Elane
elastase, neutrophil expressed
ISO
RGD
PMID:24054721
RGD:10450528
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Il17a
interleukin 17A
severity
ISO
RGD
PMID:21807912
RGD:8698654
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Mbl2
mannose binding lectin 2
ISO
DNA:SNP:exon:rs5030737(human)
RGD
PMID:17311505
RGD:8693758
NCBI chr 1:228,016,439...228,024,736
G
Ptx3
pentraxin 3
severity
ISO
DNA:SNPs, missense mutation:intron, cds:rs2305619, rs1840680, rs3816527 protein:increased expression:bronchoalveolar lavage fluid (human)
RGD
PMID:30275011 PMID:28487045
RGD:38501097 , RGD:38508892
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
S100b
S100 calcium binding protein B
ISO
RGD
PMID:21423669
RGD:5508765
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:16113258
RGD:8553022
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
susceptibility
ISO
DNA:polymorphism:exon:p.D299G(human)
RGD
PMID:18275280
RGD:5130863
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA
RGD
PMID:12917249
RGD:11528529
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cd209d
CD209d molecule
susceptibility
ISO
DNA:SNPs:3'utr,intron:multiple
RGD
PMID:22384201
RGD:39938996
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
G
Fgf2
fibroblast growth factor 2
treatment
ISO
RGD
PMID:23303813
RGD:8655596
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Il1a
interleukin 1 alpha
ISO
DNA:polymorphism, haplotype:promoter:-889C>T (human)
RGD
PMID:18484169
RGD:4142867
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
DNA:polymorphism, haplotype: :-511C>T (human)
RGD
PMID:18484169
RGD:4142867
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
IEP
protein:increased expression:respiratory system fluid/secretion, serum
RGD
PMID:24360996
RGD:40903005
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
G
Mbl2
mannose binding lectin 2
treatment
ISO
RGD
PMID:17335555
RGD:8693746
NCBI chr 1:228,016,439...228,024,736
G
Ptx3
pentraxin 3
susceptibility no_association
ISO
DNA:SNP:intron:rs1840680 (human) protein:increased expression:bronchoalveolar lavage fluid, plasma (human) protein:increased expression:plasma DNA:SNP, missense mutation:intron, cds:rs2305619, rs3816527
RGD
PMID:29020397 PMID:29964232 PMID:29020397 PMID:29020397
RGD:38501098 , RGD:38508894 , RGD:38501098 , RGD:38501098
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
RGD
PMID:23303813
RGD:8655596
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Il23a
interleukin 23 subunit alpha
severity
ISO
RGD
PMID:16157683
RGD:39457940
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Irak3
interleukin-1 receptor-associated kinase 3
severity
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:22729155 PMID:20864681
RGD:35316077 , RGD:36049798
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Lcn2
lipocalin 2
exacerbates ameliorates
ISO
protein:increased expression:lung protein:increased expression:serum
RGD
PMID:29633303 PMID:19342674 PMID:19342674 PMID:19342674 PMID:25234944 PMID:25234944 More...
RGD:126725082 , RGD:126725085 , RGD:126725085 , RGD:126725085 , RGD:126725084 , RGD:126725084
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Plac8
placenta associated 8
severity
ISO
RGD
PMID:17404296
RGD:40924563
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Trem1
triggering receptor expressed on myeloid cells 1
disease_progression
ISO
RGD
PMID:24396044
RGD:126925976
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Ada
adenosine deaminase
ISO
protein:increased expression:serum
RGD
PMID:9255891
RGD:5128857
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:16113250
RGD:4891897
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11254553
RGD:5135252
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:11254553
RGD:5135252
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11349020
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il18
interleukin 18
ISO
RGD
PMID:11083766
RGD:4889865
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
RGD
PMID:19073229
RGD:12910934
NCBI chr 1:228,016,439...228,024,736
G
Nod1
nucleotide-binding oligomerization domain containing 1
ISO
RGD
PMID:20685341
RGD:5131443
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
RGD
PMID:20685341
RGD:5131443
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Tlr5
toll-like receptor 5
susceptibility
ISO
DNA:nonsense mutation:cds:p.R392X (human) ClinVar Annotator: match by term: Legionnaire disease, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD RGD
PMID:14623910 PMID:16027372 PMID:23447684 PMID:25741868 PMID:14623910 PMID:17982089 More...
RGD:5129477 , RGD:5129510
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
G
Tlr9
toll-like receptor 9
ISO
RGD
PMID:18426877
RGD:5130707
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
RGD
PMID:18838275
RGD:5131445
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
RGD
PMID:18838275
RGD:5131445
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Ada
adenosine deaminase
ISO
protein:increased expression:serum
RGD
PMID:9255891
RGD:5128857
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Atp1b2
ATPase Na+/K+ transporting subunit beta 2
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:16988274
RGD:4892091
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:lung, secretion (mouse)
RGD
PMID:18717637
RGD:4891914
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr5
C-C motif chemokine receptor 5
ISO
protein:increased expression:lung, T-helper cell (mouse)
RGD
PMID:16988274
RGD:4892091
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Clec5a
C-type lectin domain containing 5A
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 4:69,407,125...69,416,872
Ensembl chr 4:69,407,835...69,416,859
G
Col3a1
collagen type III alpha 1 chain
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col6a1
collagen type VI alpha 1 chain
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
G
Col6a2
collagen type VI alpha 2 chain
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Crp
C-reactive protein
ISO
RGD
PMID:21426633
RGD:5131292
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Dnase1l3
deoxyribonuclease 1L3
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
G
Fcer2
Fc epsilon receptor II
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr12:1,742,809...1,754,476
Ensembl chr12:1,742,815...1,754,476
G
Flt1
Fms related receptor tyrosine kinase 1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Galc
galactosylceramidase
ISO
associated with Guillain-Barre syndrome; protein:increased expression:serum (human) associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) protein:increased expression:serum (mouse)
RGD
PMID:27490360 PMID:29301655 PMID:30396892 PMID:30396892 PMID:12225900
RGD:38599168 , RGD:38599172 , RGD:38599171 , RGD:38599171 , RGD:38599169
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
G
Hdc
histidine decarboxylase
ISO
RGD
PMID:17158962
RGD:5143920
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Htra3
HtrA serine peptidase 3
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr14:75,068,917...75,097,315
Ensembl chr14:75,068,917...75,097,315
G
Ifng
interferon gamma
ISO
mRNA:increased expression:lung:
RGD
PMID:7935058
RGD:10755754
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il13
interleukin 13
ISO
protein:increased expression:serum
RGD
PMID:20416219
RGD:4145765
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il22ra2
interleukin 22 receptor subunit alpha 2
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:14,364,489...14,377,844
G
Inhba
inhibin subunit beta A
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Klrb1
killer cell lectin like receptor B1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 4:162,456,294...162,474,989
Ensembl chr 4:162,456,294...162,474,989
G
Ms4a1
membrane spanning 4-domains A1
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
G
Pld4
phospholipase D family, member 4
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376
G
Spib
Spi-B transcription factor
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 1:95,018,939...95,024,804
Ensembl chr 1:95,018,947...95,024,780
G
Tcf7
transcription factor 7
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr10:36,423,443...36,454,350
Ensembl chr10:36,423,445...36,453,535
G
Tcl1a
Tcl1 family Akt coactivator A
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 6:124,125,032...124,131,025
Ensembl chr 6:124,125,032...124,131,025
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:serum
RGD
PMID:20416219
RGD:4145765
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf13c
TNF receptor superfamily member 13C
severity
ISO
RGD
PMID:28302172
RGD:32716376
NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:113,736,055...113,738,517
G
Ptch1
patched 1
ISO
mRNA:decreased expression:epithelium of nasopharynx
RGD
PMID:23001130
RGD:150523839
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:decreased expression:serum
RGD
PMID:19725899
RGD:5686851
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19389874
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
protein:increased expression:nasal turbinate
RGD
PMID:19364335
RGD:5147461
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Cat
catalase
ISO
protein:decreased expression:plasma
RGD
PMID:20493834
RGD:5130771
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:nasal turbinate, mucosa (human)
RGD
PMID:9865755
RGD:8548839
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:Nasal Mucosa
RGD
PMID:17982926
RGD:4145109
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:17982926
RGD:4145109
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd40
CD40 molecule
ISO
RGD
PMID:20226305
RGD:5132269
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd86
CD86 molecule
ISO
protein:increased expression:nasal mucosa, dendritic cell (human)
RGD
PMID:17088138
RGD:4892343
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Chia
chitinase, acidic
ISO
mRNA, protein:increased expression:turbinate, mucosa (human)
RGD
PMID:20422678
RGD:5037226
NCBI chr 2:193,614,374...193,656,532
Ensembl chr 2:193,614,114...193,656,533
G
Egr1
early growth response 1
ISO
DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
RGD
PMID:19833116
RGD:5131984
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
F2rl1
F2R like trypsin receptor 1
ISO
RGD
PMID:17727088
RGD:4892590
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:17181111
RGD:4142523
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hmox1
heme oxygenase 1
ISO
mRNA, protein:increased expression: nasal mucosa
RGD
PMID:16540907
RGD:4145406
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human)
RGD
PMID:19968652 PMID:19047814
RGD:4145464 , RGD:4145520
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifngr1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Il13
interleukin 13
ISO
mRNA, protein:increased expression:nasal mucosa
RGD
PMID:8520776
RGD:4782826
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il17a
interleukin 17A
severity
ISO
protein:increased expression:serum
RGD
PMID:19226302
RGD:4889151
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
susceptibility
ISO
DNA:SNP:promoter:c. -607A>C (rs1946518) (human)
RGD
PMID:16406079
RGD:4889924
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
DNA:polymorphism:exon:c.4845G>T (human)
RGD
PMID:14533660
RGD:4142859
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1r1
interleukin 1 receptor type 1
ISO
RGD
PMID:18637763
RGD:5037238
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il2
interleukin 2
ISO
protein:decreased expression:serum:
RGD
PMID:17608155
RGD:8662959
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
treatment
ISO
protein:increased expression:serum
RGD
PMID:21171297 PMID:9237816 PMID:15329007
RGD:5128559 , RGD:7829817 , RGD:7829804
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
ISO
protein: increased levels: sputum
RGD
PMID:22186238
RGD:5687140
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:14587983
RGD:4892078
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
ISO
DNA:snp:promoter:g.-786T>C (human)
RGD
PMID:18086269
RGD:4892054
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
protein:altered expression:nasal mucosa
RGD
PMID:20185258
RGD:4892593
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
mRNA, protein:increased expression:nasal mucosa (human)
RGD
PMID:17116814
RGD:8552811
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Tbxa2r
thromboxane A2 receptor
treatment
ISO
RGD
PMID:15247523
RGD:11059532
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Plau
plasminogen activator, urokinase
ISO
Gene product used in treatment of disease
RGD
PMID:20304453
RGD:4891955
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Tnc
tenascin C
ISO
protein:increased expression:pleura
RGD
PMID:10950882
RGD:4889594
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Trem1
triggering receptor expressed on myeloid cells 1
treatment
IDA
RGD
PMID:20819512
RGD:127284851
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Ada
adenosine deaminase
ISO
protein:increased activity:pleural fluid: protein:increased activity:serum: protein:increased expression:serum:
RGD
PMID:21860532 PMID:1818842 PMID:1689629 PMID:18357489
RGD:152995280 , RGD:152998934 , RGD:152995292 , RGD:152995288
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Ccl22
C-C motif chemokine ligand 22
ISO
RGD
PMID:20337996
RGD:4891473
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:19159432
RGD:4145106
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
ISO
protein:increased expression:pleural fluid, natural killer cell (human)
RGD
PMID:19159432
RGD:4145106
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Foxp3
forkhead box P3
disease_progression
ISO
associated with human immunodeficiency virus infectious disease;
RGD
PMID:21303360
RGD:36947878
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Il1b
interleukin 1 beta
ISO
DNA:polymorphism: :3953T>C (human)
RGD
PMID:10377182
RGD:4143226
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
DNA:repeat (human)
RGD
PMID:10377182
RGD:4143226
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il27
interleukin 27
exacerbates
ISO
associated with Pleural Effusion;protein:increased expression:pleural fluid (human) protein:increased expression:alveolar system (human)
RGD
PMID:25753767 PMID:31819557 PMID:23962500 PMID:28844060
RGD:126790505 , RGD:126790549 , RGD:126790523 , RGD:126790517
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il33
interleukin 33
ISO
protein:increased expression:pleural fluid:
RGD
PMID:23301222
RGD:39939042
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:pleura:
RGD
PMID:18715875
RGD:5129700
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:18295348
RGD:4144193
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnc
tenascin C
ISO
protein:increased expression:pleura
RGD
PMID:10950882
RGD:4889594
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Ada
adenosine deaminase
ISO
RGD
PMID:16860713
RGD:5128847
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Alox5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:9109363
RGD:4890429
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Anxa1
annexin A1
IDA
RGD
PMID:15784654
RGD:2306907
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Bdkrb1
bradykinin receptor B1
IMP
RGD
PMID:11853231
RGD:5129218
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
ISO IMP
RGD
PMID:15316088 PMID:9208140
RGD:4891029 , RGD:4891041
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
C3
complement C3
ISO
protein:increased activity:pleural cavity
RGD
PMID:18256172
RGD:5129520
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cat
catalase
ISO
RGD
PMID:19778612
RGD:5130749
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl11
C-C motif chemokine ligand 11
ISO IMP
protein:increased expression:pleural fluid
RGD
PMID:11877329 PMID:11564646
RGD:4145443 , RGD:4145479
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl25
C-C motif chemokine ligand 25
ISO
protein:increased expression:pleural fluid
RGD
PMID:18056919
RGD:5130924
NCBI chr12:2,707,398...2,716,571
Ensembl chr12:2,707,398...2,716,554
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:lung (mouse)
RGD
PMID:18672096
RGD:4890016
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr3
C-C motif chemokine receptor 3
ISO
associated with Mycobacterium Infections
RGD
PMID:17158890
RGD:4145643
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Csf3
colony stimulating factor 3
ISO
RGD
PMID:8841835
RGD:11039424
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
RGD
PMID:14527170
RGD:5135449
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:14527170
RGD:5135449
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP ISO
RGD
PMID:21549112 PMID:14527170
RGD:5135064 , RGD:5135449
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:14527170
RGD:5135449
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Ednra
endothelin receptor type A
ISO
RGD
PMID:15107459
RGD:4892325
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Elane
elastase, neutrophil expressed
IMP
RGD
PMID:20860667
RGD:10450565
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:17035596
RGD:4892303
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Icam1
intercellular adhesion molecule 1
ISO
associated with Tuberculosis; protein:increased expression:pleural fluid, natural killer cell (human) CTD Direct Evidence: marker/mechanism protein:increased expression:bronchial epithelium (mouse)
CTD RGD
PMID:11181422 PMID:19714575 PMID:19056932
RGD:4145510 , RGD:4145519
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11181422
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il15
interleukin 15
ISO
RGD
PMID:10823416
RGD:4990464
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17a
interleukin 17A
treatment
IDA
RGD
PMID:21898269
RGD:7175307
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
IDA ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:pleural cavity, exudate (rat) protein:increased expression:lung
CTD RGD
PMID:11181422 PMID:20141620 PMID:21898269 PMID:20175894
RGD:4142808 , RGD:7175307 , RGD:4142826
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
RGD
PMID:8491511
RGD:4143233
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11181422
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mpo
myeloperoxidase
ISO
protein:increased activity:lung
RGD
PMID:11577999
RGD:5130991
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
RGD
PMID:14673141
RGD:6893408
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
IEP IDA
protein:increased expression:pleural cavity (rat)
RGD
PMID:21898269 PMID:20141620
RGD:7175307 , RGD:4142808
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Pla2g6
phospholipase A2 group VI
IEP
RGD
PMID:15003994
RGD:6482741
NCBI chr 7:110,851,378...110,891,557
Ensembl chr 7:110,851,378...110,891,114
G
Ptafr
platelet-activating factor receptor
treatment
IMP
RGD
PMID:8395390
RGD:10043147
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IDA IEP
RGD
PMID:20141620 PMID:15740981
RGD:4142808 , RGD:5143929
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Selp
selectin P
ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11181422 PMID:21147071
RGD:6219005
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Serpine1
serpin family E member 1
susceptibility
ISO
associated with Familial Mediterranean Fever;DNA: DNA:polymorphism:promoter:rs1799768 (human):
RGD
PMID:23052617
RGD:13207414
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Tnf
tumor necrosis factor
ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11181422 PMID:15380531 PMID:11161459 PMID:20141620
RGD:4143474 , RGD:4142808
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf8
TNF superfamily member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15380531
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Alox5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:12773506
RGD:4890419
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Aicda
activation-induced cytidine deaminase
ISO
RGD
PMID:26456931
RGD:11098923
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
G
Alox5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:20231413
RGD:4890435
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Btk
Bruton tyrosine kinase
ameliorates
ISO
RGD
PMID:30646846
RGD:124715470
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
G
C3
complement C3
disease_progression
ISO IEP
protein:decreased expression:serum associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion
RGD
PMID:20405 PMID:17956621 PMID:15972516
RGD:5130163 , RGD:5129523 , RGD:5129509
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C5
complement C5
severity
ISO
RGD
PMID:7814608
RGD:5130159
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Ccl5
C-C motif chemokine ligand 5
susceptibility
ISO
RGD
PMID:16455992
RGD:4892130
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cd14
CD14 molecule
ISO
RGD
PMID:17185649
RGD:4144788
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Chi3l1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:10515841
RGD:4892626
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
RGD
PMID:21774994
RGD:5147472
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Crhr2
corticotropin releasing hormone receptor 2
ISO
RGD
PMID:21774994
RGD:5147472
NCBI chr 4:84,222,897...84,265,924
Ensembl chr 4:84,224,002...84,265,904
G
Crp
C-reactive protein
disease_progression
ISO
RGD
PMID:21281676
RGD:5131293
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20958976
RGD:5134957
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:lung
RGD
PMID:20381636
RGD:5135285
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Defb5
defensin beta 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr16:70,612,985...70,615,389
Ensembl chr16:70,613,146...70,615,467
G
Hmox1
heme oxygenase 1
ISO
associated with influenza;protein:increased expression:lung
RGD
PMID:17348295
RGD:4145366
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
ISO
RGD
PMID:19396720
RGD:5147385
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Il15
interleukin 15
ISO
protein:increased expression:alveolar macrophage, bronchial epithelial cell
RGD
PMID:17611121
RGD:5000755
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il15ra
interleukin 15 receptor subunit alpha
ISO
RGD
PMID:17611121
RGD:5000755
NCBI chr17:66,802,300...66,831,973
Ensembl chr17:66,802,334...66,832,278
G
Il17a
interleukin 17A
ISO
RGD
PMID:19995896
RGD:4888531
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO
RGD
PMID:15770015
RGD:4889960
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il6
interleukin 6
ISO
RGD
PMID:20643849
RGD:4143255
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lep
leptin
ISO
RGD
PMID:17822444
RGD:5128869
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
ISO
RGD
PMID:21148797
RGD:5128846
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Masp2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580
G
Mbl2
mannose binding lectin 2
no_association
ISO
DNA:mutations:5' utr, exon:multiple (human) DNA:polymorphisms:5' utr, exon:multiple (human)
RGD
PMID:18641104 PMID:12047967
RGD:4889477 , RGD:4889478
NCBI chr 1:228,016,439...228,024,736
G
Nos2
nitric oxide synthase 2
ISO
RGD
PMID:17056580
RGD:4891950
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Pten
phosphatase and tensin homolog
ameliorates
ISO
myeloid knockout
RGD
PMID:20505137
RGD:127285597
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Sftpd
surfactant protein D
severity
ISO
RGD
PMID:16255775
RGD:4143519
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24894820
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sting1
stimulator of interferon response cGAMP interactor 1
ISO
RGD
PMID:29263110
RGD:39128230
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:19956717
RGD:4145321
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tnf
tumor necrosis factor
ISO
associated with influenza;protein:increased expression:lung
RGD
PMID:9032201 PMID:17348295
RGD:4143479 , RGD:4145366
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates
ISO
RGD
PMID:24752755 PMID:19596984
RGD:126928121 , RGD:127229903
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Azin1
antizyme inhibitor 1
IEP
mRNA:increased expression:alveolar macrophage
RGD
PMID:19158080
RGD:14700806
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
G
C3
complement C3
IEP
RGD
PMID:17169032
RGD:5129525
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20618689
RGD:4891428
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:10968950
RGD:8547797
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Csf2
colony stimulating factor 2
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19487471
RGD:5131475
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Il23a
interleukin 23 subunit alpha
ISO
RGD
PMID:17403873
RGD:39458043
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il33
interleukin 33
treatment
ISO
RGD
PMID:21220696
RGD:40400892
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Muc1
mucin 1, cell surface associated
ISO
protein:increased expression:serum
RGD
PMID:9617869
RGD:5131424
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Nos2
nitric oxide synthase 2
IEP
mRNA:increased expression:alveolar macrophage protein:decreased dimerization:alveolar macrophage
RGD
PMID:20377877 PMID:20558778
RGD:4144112 , RGD:4891486
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
RT1-Bb
RT1 class II, locus Bb
IEP
RGD
PMID:20377877
RGD:4144112
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Sftpa1
surfactant protein A1
ISO
protein:increased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpb
surfactant protein B
ISO
protein:decreased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Sftpc
surfactant protein C
ISO
protein:decreased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Sftpd
surfactant protein D
ISO
protein:increased expression:lung
RGD
PMID:11385364
RGD:4143431
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:18400546
RGD:4145341
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Abcf1
ATP binding cassette subfamily F member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr20:2,802,519...2,815,433
Ensembl chr20:2,802,488...2,815,433
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
severity
ISO
DNA:polymorphism:cds:allele A (human)
RGD
PMID:4375858
RGD:39938844
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
G
Ace
angiotensin I converting enzyme
disease_progression
ISO
associated with Hypertension
RGD
PMID:17727310 PMID:19455553 PMID:20051911
RGD:4140922 , RGD:4140918 , RGD:4140916
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adora1
adenosine A1 receptor
ISO
RGD
PMID:15630442
RGD:5129098
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2a
adenosine A2a receptor
ISO
associated with Lung Injury associated with Anemia, Sickle Cell
RGD
PMID:18703794 PMID:20798237 PMID:17601796
RGD:4890364 , RGD:4890358 , RGD:4890376
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adrb2
adrenoceptor beta 2
IDA
RGD
PMID:19925785
RGD:4145041
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28960804
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23337360
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Alb
albumin
disease_progression
ISO
RGD
PMID:23286966
RGD:11035283
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Bdkrb2
bradykinin receptor B2
ISO
RGD
PMID:15021973
RGD:4891030
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
C3
complement C3
IDA
RGD
PMID:10886251
RGD:5129562
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C3ar1
complement C3a receptor 1
ISO
associated with Respiratory Syncytial Virus Infections
RGD
PMID:17079327
RGD:5129688
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
C5
complement C5
ISO
associated with Respiratory Syncytial Virus Infections
RGD
PMID:17079327 PMID:3631740
RGD:5129688 , RGD:5130161
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Casp1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Ccl11
C-C motif chemokine ligand 11
IMP ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:lung, respiratory system fluid/secretion
CTD RGD
PMID:21625544 PMID:10595930 PMID:11290805
RGD:4145450 , RGD:4145445
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl12
C-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
G
Ccl17
C-C motif chemokine ligand 17
IEP ISO
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:15993846
RGD:2306304
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl19
C-C motif chemokine ligand 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:19648283
RGD:4891461
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
IEP
mRNA:increased expression:lung
RGD
PMID:15993846
RGD:2306304
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl24
C-C motif chemokine ligand 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl3
C-C motif chemokine ligand 3
ISO
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl7
C-C motif chemokine ligand 7
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:15191918
RGD:5130985
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccr1
C-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20870892
RGD:5688175
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:14615370 PMID:17284325
RGD:4145068 , RGD:8661704
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
ISO
mRNA:increased expression:lung
RGD
PMID:19762220
RGD:4145622
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
ISO
Idiopathic Pneumonia Syndrome; mRNA:increased expression:lung (mouse)
RGD
PMID:15546955
RGD:4892103
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Ccr6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Ccr7
C-C motif chemokine receptor 7
ISO
mRNA, protein:increased expression:lung
RGD
PMID:16394278
RGD:5130919
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Ccr9
C-C motif chemokine receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 8:123,396,157...123,410,199
Ensembl chr 8:123,395,813...123,413,969
G
Cd14
CD14 molecule
ISO
protein:increased expression:multiple
RGD
PMID:20302606
RGD:4144794
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd163
CD163 molecule
ISO
associated with liver disease;protein:increased expression:blood serum (human)
RGD
PMID:26339412
RGD:11251207
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
G
Cd40lg
CD40 ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Crhr2
corticotropin releasing hormone receptor 2
ISO
RGD
PMID:16855006
RGD:5130933
NCBI chr 4:84,222,897...84,265,924
Ensembl chr 4:84,224,002...84,265,904
G
Crp
C-reactive protein
severity disease_progression
ISO
RGD
PMID:21258955 PMID:21439658
RGD:5131283 , RGD:5131291
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf2
colony stimulating factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11732872 PMID:19633061
RGD:4142837
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf3r
colony stimulating factor 3 receptor
ISO
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Csk
C-terminal Src kinase
ISO
RGD
PMID:14975240
RGD:5134363
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP ISO
mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20728373
RGD:5134959
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung
RGD
PMID:15265940 PMID:14979941
RGD:5135445 , RGD:5135491
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP ISO
mRNA, protein:increased expression:lung mRNA:increased expression:lung
RGD
PMID:20728373 PMID:18367723
RGD:5134959 , RGD:5135235
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
protein:increased expression:sputum
RGD
PMID:18410262
RGD:5135259
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:17052299 PMID:15265940
RGD:5135440 , RGD:5135445
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung
CTD RGD
PMID:21625544 PMID:15265940 PMID:14979941
RGD:5135445 , RGD:5135491
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:15928955
RGD:4142512
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
protein:increased expression:alveolus, epithelial cell DNA:polymorphism (human)
RGD
PMID:14698565 PMID:15928955
RGD:4892223 , RGD:4142512
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Defb1
defensin beta 1
ISO
protein:increased expression:serum
RGD
PMID:17000097
RGD:4892262
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Edn1
endothelin 1
severity
ISO
protein:increased secretion:plasma (human)
RGD
PMID:20529344
RGD:4144879
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Egf
epidermal growth factor
resistance
ISO
RGD
PMID:21701422
RGD:6906904
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egr1
early growth response 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29787794
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Fcgr3a
Fc gamma receptor 3A
treatment
ISO
associated with Hodgkin Disease;DNA:SNP:exon:p.F158V (rs396991) (human)
RGD
PMID:20423913
RGD:11352258
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Grp
gastrin releasing peptide
ISO
protein:increased expression:serum (human)
RGD
PMID:30146822
RGD:401700396
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
G
Hdc
histidine decarboxylase
ISO
RGD
PMID:14556983
RGD:5143922
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hmox1
heme oxygenase 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16582079 PMID:16582079
RGD:1601608
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
associated with Reperfusion Injury
RGD
PMID:22882462
RGD:8547727
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifnar1
interferon alpha and beta receptor subunit 1
resistance
ISO
Cryptococcus (yeast) pneumonia
RGD
PMID:18566423 PMID:18566423
RGD:5490275 , RGD:5490275
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31095431 PMID:20080200
RGD:7495767
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
disease_progression
ISO
protein:increased expression:blood
RGD
PMID:20595152
RGD:4140400
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
ISO
associated with Respiratory Distress Syndrome, Newborn; protein:increased expression:bronchoalveolar lavage fluid CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:19695190
RGD:4145774
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
mRNA:increased expression:lung, fibroblast
RGD
PMID:15161635
RGD:4890021
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20498020 PMID:22848348
RGD:4888524 , RGD:9068417
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO IEP
protein:increased expression:serum CTD Direct Evidence: marker/mechanism associated with reperfusion injury mRNA, protein:increased expression:lung,bronchoalveolar fluid
CTD RGD
PMID:21625544 PMID:15955140 PMID:16052682 PMID:11739527 PMID:17400729
RGD:4889836 , RGD:4889825 , RGD:729357 , RGD:4889590
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
IEP
mRNA:increased expression:lung
RGD
PMID:8806881
RGD:7794765
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung protein:increased expression:lung mRNA, protein:increased expression:lung
CTD RGD
PMID:21625544 PMID:20007584 PMID:20476872 PMID:19901996 PMID:19825784 PMID:20155581 More...
RGD:4142812 , RGD:4142536 , RGD:4143211 , RGD:4142831 , RGD:4142827
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il1r2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il1rn
interleukin 1 receptor antagonist
no_association disease_progression
ISO IEP
mRNA:increased expression:lung mRNA:increased expression:bronchioalveolar lavage fluid, neutrophil (rat) DNA:polymorphism (human) DNA:polymorphism:intron (human)
RGD
PMID:17569781 PMID:1385928 PMID:16369129 PMID:19900796 PMID:18838927
RGD:4142871 , RGD:8551846 , RGD:4143213 , RGD:4143204 , RGD:4142865
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il27
interleukin 27
ISO
RGD
PMID:19124731
RGD:5128483
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il2rb
interleukin 2 receptor subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
G
Il33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24453940
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
ISO
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il5ra
interleukin 5 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 4:139,630,652...139,664,593
Ensembl chr 4:139,632,066...139,668,544
G
Il6
interleukin 6
disease_progression
ISO
protein:increased expression:blood CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:20595152
RGD:4140400
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Irf5
interferon regulatory factor 5
severity
ISO
RGD
PMID:29847542
RGD:40907064
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
Itga2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:11207307
RGD:8693217
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga4
integrin subunit alpha 4
treatment
IMP
RGD
PMID:8703473
RGD:9698424
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itgb2
integrin subunit beta 2
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21625544 PMID:10030843
RGD:6482228
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Itgb3
integrin subunit beta 3
disease_progression
ISO
RGD
PMID:12746502
RGD:5100478
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Lcn2
lipocalin 2
exacerbates
ISO
associated with Escherichia Coli Infections
RGD
PMID:20633248
RGD:126779583
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lias
lipoic acid synthetase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:32017981
NCBI chr14:42,876,699...42,893,824
Ensembl chr14:42,876,699...42,893,783
G
Mbl2
mannose binding lectin 2
ISO
protein:increased secretion:lung (human) protein:increased expression:Bronchoalveolar lavage:
RGD
PMID:18988662 PMID:15249448
RGD:4889459 , RGD:8693755
NCBI chr 1:228,016,439...228,024,736
G
Mif
macrophage migration inhibitory factor
severity
ISO
DNA:repeats:promoter
RGD
PMID:19346297
RGD:4891058
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir150
microRNA 150
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29205062
NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:95,605,024...95,605,108
G
Mir20a
microRNA 20a
ISO
RGD
PMID:29115456
RGD:25823151
NCBI chr15:92,181,084...92,181,168
Ensembl chr15:92,181,084...92,181,168
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:18007984
RGD:5130157
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc1
mucin 1, cell surface associated
ISO
protein:increased expression:serum
RGD
PMID:11802251
RGD:5131281
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Muc2
mucin 2, oligomeric mucus/gel-forming
treatment
IDA
RGD
PMID:23590300
RGD:7349359
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Myd88
MYD88, innate immune signal transduction adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26882889
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Mylk
myosin light chain kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15863634
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
Nfkbia
NFKB inhibitor alpha
susceptibility
ISO
associated with combined immunodeficiency;DNA:missense mutation:CDS:c.106T>G (p.S36A) (human)
RGD
PMID:31683054
RGD:126925985
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nrp1
neuropilin 1
treatment
ISO
RGD
PMID:36373992
RGD:401901166
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20561897
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pf4
platelet factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6254450
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Reg3b
regenerating family member 3 beta
IDA
RGD
PMID:12579542
RGD:9831426
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
G
Serpine1
serpin family E member 1
disease_progression
ISO
Pneumonia, Ventilator-Associated; protein:increased expression:Bronchoalveolar Lavage Fluid DNA:polymorphism:promoter:
RGD
PMID:20473240 PMID:19387177
RGD:4143511 , RGD:4143525
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sftpa1
surfactant protein A1
ISO
protein:decreased expression:lung
RGD
PMID:15967375 PMID:8542113
RGD:4143394 , RGD:4143452
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpb
surfactant protein B
ISO
RGD
PMID:12594064 PMID:16024721 PMID:15967375
RGD:4143412 , RGD:4143393 , RGD:4143394
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Sftpc
surfactant protein C
ISO
RGD
PMID:15967375
RGD:4143394
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Sftpd
surfactant protein D
ISO
associated with Bronchitis;protein:decreased expression:lung
RGD
PMID:18266831 PMID:17925426 PMID:15967375
RGD:4143517 , RGD:4143504 , RGD:4143394
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24633890
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc11a2
solute carrier family 11 member 2
IMP
RGD
PMID:21278260
RGD:5688709
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:16842247
RGD:1581268
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tgfb1
transforming growth factor, beta 1
severity
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:21625544 PMID:19181604 PMID:19965809
RGD:4145141 , RGD:4145120
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
susceptibility
ISO
RGD
PMID:19011150
RGD:4145330
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26882889 PMID:20357263
RGD:4142858
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnc
tenascin C
ISO
protein:increased expression:serum, respiratory system fluid/secretion
RGD
PMID:19721293
RGD:4889573
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21625544 PMID:28917655 PMID:34390737
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625544
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
susceptibility
ISO
Idiopathic Pneumonia Syndrome CTD Direct Evidence: marker/mechanism associated with Carcinoma, Non-Small-Cell Lung; DNA:snp:cds:p.M196R rs1061622 (human)
CTD RGD
PMID:21625544 PMID:18664626 PMID:20811626
RGD:5131448 , RGD:5131286
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfsf12
TNF superfamily member 12
ISO
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr10:54,403,870...54,413,213
Ensembl chr10:54,403,870...54,413,213
G
Vdr
vitamin D receptor
susceptibility
ISO
DNA:SNP: :rs2239185(human)
RGD
PMID:17224129 PMID:25367052
RGD:4889851 , RGD:11074745
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Gc
GC, vitamin D binding protein
ISO
protein:increased expression:bronchoalveolar fluid:
RGD
PMID:21136918
RGD:5509873
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Ido1
indoleamine 2,3-dioxygenase 1
ISO
RGD
PMID:20385761
RGD:39938865
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
G
Ptx3
pentraxin 3
ISO
protein:increased expression:bronchoalveolar lavage fluid, plasma (human)
RGD
PMID:29964232
RGD:38508894
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Abcb1a
ATP binding cassette subfamily B member 1A
treatment
ISO
DNA:SNP: :2677G>A (human)
RGD
PMID:26067842
RGD:11098541
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Ada
adenosine deaminase
ISO
protein:increased expression:plasma, respiratory system fluid/secretion protein:increased activity:sputum: protein:increased activity:blood, pulmonary alveolar duct
RGD
PMID:12194640 PMID:19460251 PMID:2212911
RGD:5128854 , RGD:152995271 , RGD:152995390
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:plasma
RGD
PMID:22022605
RGD:5686405
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Akt1
AKT serine/threonine kinase 1
susceptibility
ISO
DNA:SNP,haplotype:intron: IVS3+18 C/C (human)
RGD
PMID:20141546
RGD:38676498
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alox5
arachidonate 5-lipoxygenase
susceptibility
ISO
DNA:polymorphism, repeat:promoter, exon:g.760G>A (human)
RGD
PMID:18174194
RGD:4890411
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Asap1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25774636
NCBI chr 7:95,786,130...96,093,111
Ensembl chr 7:95,787,818...96,092,754
G
Atf3
activating transcription factor 3
ISO
mRNA,protein:increased expression:lung
RGD
PMID:20856677
RGD:34888225
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
C3
complement C3
ISO
RGD
PMID:19472039
RGD:5129500
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Ccl1
C-C motif chemokine ligand 1
susceptibility
ISO
mRNA:increased expression:lung, dendritic cell DNA:SNP: :multiple (human)
RGD
PMID:18703681 PMID:19057661
RGD:4891409 , RGD:4891408
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccl19
C-C motif chemokine ligand 19
ISO
mRNA:increased expression:lung
RGD
PMID:19933855
RGD:5130906
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl2
C-C motif chemokine ligand 2
susceptibility
ISO
DNA:polymorphism: :-2518A>G (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16352737 PMID:18940815 PMID:20111728
RGD:4891439
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
susceptibility
ISO
DNA:snps:5' utr:g.-403G>A rs2280788, g.-28C>G rs2107538 (human) mRNA:increased expression:lung (human)
RGD
PMID:19335954 PMID:15128813
RGD:4891879 , RGD:4892112
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr2
C-C motif chemokine receptor 2
disease_progression
ISO
RGD
PMID:11438742
RGD:734715
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
ISO
protein:decreased expression:blood, T cell (human)
RGD
PMID:16379602
RGD:4892094
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd14
CD14 molecule
susceptibility
ISO
DNA:polymorphism:promoter:c. -159C>T (human)|protein:increased expression:monocyte, serum
RGD
PMID:18008256 PMID:18008256
RGD:4144205 , RGD:4144205
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd163
CD163 molecule
exacerbates
ISO
protein:increased expression:blood plasma, CD14-positive monocyte (human) protein:increased expression:blood serum (human)
RGD
PMID:27685837 PMID:27684274
RGD:127285801 , RGD:127345136
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
G
Cd1d1
CD1d1 molecule
susceptibility
ISO
DNA:SNPS, haplotype:intron, enhancer: (rs859009,rs859010, rs973742) (human)
RGD
PMID:30972222
RGD:127345096
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
G
Cd209d
CD209d molecule
susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with HIV Seropositivity; DNA:SNP:promoter: -336A>G (rs4804803) (human) DNA:SNPs:promoter:-139G>A, -336A>G, -871A>G (rs2287886,rs4804803,rs735239) (human)
CTD RGD
PMID:16379498 PMID:19126442 PMID:24874302
RGD:39939062 , RGD:39938981
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
G
Cd274
CD274 molecule
ISO
protein:increased expression:Tcell, B cell, monocyte
RGD
PMID:23661793
RGD:40818418
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd36
CD36 molecule
susceptibility
ISO
DNA:SNPs: :rs1194182, rs10499859(human)
RGD
PMID:28693442
RGD:41412192
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd86
CD86 molecule
ISO
protein:decreased expression:sputum, macrophage (human)
RGD
PMID:17713660
RGD:4892339
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Clec4m
C-type lectin domain family 4 member M
susceptibility
ISO
DNA:repeats:exon 4: allele 4, allele 5, allele 9 (human)
RGD
PMID:19770268 PMID:24874302 PMID:17224292
RGD:39938983 , RGD:39938981 , RGD:39938987
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
G
Crp
C-reactive protein
severity
ISO
associated with HIV Infections
RGD
PMID:21219690 PMID:21197091
RGD:5131284 , RGD:5131287
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cxcl10
C-X-C motif chemokine ligand 10
treatment
ISO
RGD
PMID:29843631
RGD:27095956
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
disease_progression
ISO
RGD
PMID:20454613
RGD:5135037
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
susceptibility
ISO
mRNA:increased expression:lung
RGD
PMID:16790804
RGD:5135246
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cyba
cytochrome b-245 alpha chain
no_association
ISO
DNA:SNPs:exons:214C>T (rs4673), 521C>T (rs17845095) (human)
RGD
PMID:16608528
RGD:4780358
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Ddit3
DNA-damage inducible transcript 3
ISO
mRNA,protein:increased expression:lung
RGD
PMID:20856677
RGD:34888225
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Egfr
epidermal growth factor receptor
disease_progression
ISO
associated with lung adenocarcinoma;
RGD
PMID:29621876 PMID:22173705
RGD:38599162 , RGD:38599176
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Ereg
epiregulin
susceptibility
ISO
DNA:SNP:exon 4: (rs2367707) (human)
RGD
PMID:30634928
RGD:39457687
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Foxp3
forkhead box P3
susceptibility
ISO
DNA:polymorphism:promoter:-924A>G(human)
RGD
PMID:29020928
RGD:38501101
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gbe1
1,4-alpha-glucan branching enzyme 1
ISO
DNA:SNP:intron:rs2307058 (human)
RGD
PMID:28355295
RGD:18337291
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
associated with GSTT1 null deletion; DNA:deletion: :
RGD
PMID:20297661
RGD:4140932
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:20297661
RGD:4140932
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Havcr2
hepatitis A virus cellular receptor 2
ISO
RGD
PMID:21382414
RGD:5135524
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Ido1
indoleamine 2,3-dioxygenase 1
treatment
ISO
RGD
PMID:32369456
RGD:39939073
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
G
Il13
interleukin 13
ISO
mRNA:increased expression:Leukocytes, Mononuclear
RGD
PMID:10608794
RGD:4145649
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il15
interleukin 15
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11742275
RGD:4990461
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il18
interleukin 18
ISO
protein:increased expression:serum
RGD
PMID:15955140
RGD:4889836
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
RGD
PMID:9176116
RGD:4142835
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
severity susceptibility
ISO
protein:increased expression:lung DNA:polymorphism: :3953T>C (human) protein:increased expression:bronchioalveolar lavage fluid (human)
RGD
PMID:10543265 PMID:16634865 PMID:10631206
RGD:4143180 , RGD:5147843 , RGD:4143179
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
ISO
RGD
PMID:28128217
RGD:39938965
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il1rn
interleukin 1 receptor antagonist
severity
ISO
protein:increased expression:lung, serum
RGD
PMID:10543265 PMID:14619382 PMID:10631206
RGD:4143180 , RGD:4143174 , RGD:4143179
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il23a
interleukin 23 subunit alpha
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:16002675 PMID:21156751 PMID:20624887 PMID:11801672
RGD:39457949 , RGD:39458038 , RGD:39458036 , RGD:39457953
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il27
interleukin 27
exacerbates
ISO
DNA:SNPs:promoter, exon:-964A>G, 2905T>G (human) DNA:SNPs:promoter,exons:-964A>G, 2905T>G, 4730T>C (rs153109, rs17855750, rs181206) (human)
RGD
PMID:31949807 PMID:30948177
RGD:126790508 , RGD:39456132
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il27ra
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:15749890
RGD:5128486
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
G
Il33
interleukin 33
ISO
RGD
PMID:28128217
RGD:39938965
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
severity
ISO
RGD
PMID:20832364
RGD:5128550
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
ISO
protein:decreased expression:serum
RGD
PMID:21251883
RGD:5128510
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
ISO
RGD
PMID:20624776
RGD:4143257
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
protein:decreased expression:T cell
RGD
PMID:20019339
RGD:5128632
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Irf1
interferon regulatory factor 1
ISO
RGD
PMID:11083808
RGD:5128719
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
protein:increased expression:urine
RGD
PMID:29636444
RGD:40903003
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
protein:decreased phosphorylation:macrophage, nucleus
RGD
PMID:19737230
RGD:4889999
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Lcn2
lipocalin 2
exacerbates disease_progression
ISO
RGD
PMID:19050270 PMID:30534124
RGD:126779558 , RGD:126779565
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lta
lymphotoxin alpha
susceptibility
ISO
DNA:polymorphism:intron:252G>A (human)
RGD
PMID:20180006
RGD:4143234
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Marco
macrophage receptor with collagenous structure
susceptibility
ISO
DNA:SNP: :rs12998782(human) DNA:SNPs:introns:rs4491733,rs12998782,rs13389814,rs7559955 (human) DNA:SNPs: :rs2278589, rs6751745,rs6748401 (human)
RGD
PMID:28693442 PMID:23617307 PMID:27853145
RGD:41412192 , RGD:41412195 , RGD:41412194
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
G
Mbl2
mannose binding lectin 2
ISO
DNA:polymorphisms:5' utr, exon:multiple (human)
RGD
PMID:19199550
RGD:4889452
NCBI chr 1:228,016,439...228,024,736
G
Mif
macrophage migration inhibitory factor
susceptibility
ISO
DNA:SNP: :rs755622 (human)
RGD
PMID:20439102
RGD:4891004
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir30a
microRNA 30a
disease_progression
ISO
RGD
PMID:25866116
RGD:35668864
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
G
Mmp3
matrix metallopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24890593
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24890593
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Mmp8
matrix metallopeptidase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24890593
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:16982845
RGD:5130746
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
RGD
PMID:20297661
RGD:4140932
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfkbia
NFKB inhibitor alpha
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:9379002
RGD:126908014
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO
DNA:SNPs:CDs:p.P268S, R702W, A725G (human)
RGD
PMID:18419343
RGD:5131510
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
ISO
DNA:SNPs:multiple (human)
RGD
PMID:19575238
RGD:4144122
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Pdcd1
programmed cell death 1
treatment
ISO
protein:increased expression:Tcell, B cell, monocyte
RGD
PMID:23661793 PMID:23661793
RGD:40818418 , RGD:40818418
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pdcd1lg2
programmed cell death 1 ligand 2
ISO
protein:increased expression:Tcell, B cell, monocyte
RGD
PMID:23661793
RGD:40818418
NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:227,158,941...227,223,938
G
Plaur
plasminogen activator, urokinase receptor
severity
ISO
RGD
PMID:18359089
RGD:6483832
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
ISO
DNA:SNPs:cds:788G>A, 1858C>T (human)
RGD
PMID:19563523
RGD:6484723
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
RT1-Bb
RT1 class II, locus Bb
disease_progression susceptibility
ISO
DNA:polymorphisms (human) DNA:polymorphism: :HLA-DQB1*3:03(human) DNA:polymorphism:cds:HLA-DQB1*0201(human)
RGD
PMID:19230186 PMID:28612994 PMID:24024195
RGD:5147614 , RGD:36049765 , RGD:36049753
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphism:cds:HLA-DRB1*0201(human) DNA:polymorphism: :HLA-DRB1*09:01(human)
RGD
PMID:24024195 PMID:28612994
RGD:36049753 , RGD:36049765
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
ISO
RGD
PMID:18652916
RGD:5144001
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Sftpa1
surfactant protein A1
susceptibility
ISO
DNA:SNPs:exons:307G>A, 776C>T (human) DNA:SNP:intron:1416C>T (human)
RGD
PMID:16292672 PMID:12476938
RGD:4144874 , RGD:4144875
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Slc11a1
solute carrier family 11 member 1
susceptibility
ISO
DNA:polymorphism:intron (human) DNA:deletion:3'UTR:
RGD
PMID:21169917 PMID:24024195
RGD:5684974 , RGD:36049753
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Tap1
transporter 1, ATP binding cassette subfamily B member
ISO
associated with HIV Infections;
RGD
PMID:21843574
RGD:6482248
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tap2
transporter 2, ATP binding cassette subfamily B member
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:9062973
RGD:5147851
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Tlr1
toll-like receptor 1
ISO
mRNA:increased expression:blood
RGD
PMID:16493059
RGD:4889525
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr2
toll-like receptor 2
susceptibility
ISO
DNA:polymorphism:intron (human) DNA:polymorphisms: :multiple (human) DNA:SNP: :rs1816702 (human) mRNA, protein:increased expression:blood, T cell
RGD
PMID:20298136 PMID:20113509 PMID:19723394 PMID:19552525
RGD:4145304 , RGD:4145320 , RGD:4145323 , RGD:4145355
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
severity susceptibility
ISO
DNA:polymorphisms:cds: p. D299F, T399I (human) DNA:SNP:intron: rs5030729 (human) protein:increased expression:monocyte
RGD
PMID:20403143 PMID:19575238 PMID:18008256
RGD:4144106 , RGD:4144122 , RGD:4144205
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr9
toll-like receptor 9
ISO
DNA:snps:multiple (human)
RGD
PMID:19771452
RGD:5130704
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
susceptibility disease_progression
ISO
DNA:polymorphisms::c.-857 C>T, c. -863 A>C (human)
RGD
PMID:20650298 PMID:9176116 PMID:18212516
RGD:4143388 , RGD:4142835 , RGD:4143395
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trem1
triggering receptor expressed on myeloid cells 1
disease_progression
ISO
RGD
PMID:29844416
RGD:126925977
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Vdr
vitamin D receptor
susceptibility
ISO
DNA:SNP (human) DNA:SNPs:5' UTR (human) DNA:SNPs:promoter, 3' UTR (human) DNA:SNPs (human)
RGD
PMID:17236578 PMID:20231985 PMID:18397302 PMID:18231846 PMID:15295697
RGD:4889849 , RGD:4889830 , RGD:4889842 , RGD:4889845 , RGD:4889853
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Cd274
CD274 molecule
ISO
protein:increased expression: larynx
RGD
PMID:22322668
RGD:40822813
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Foxp3
forkhead box P3
susceptibility
ISO
DNA:SNPs:promoter:rs5902434,rs2232365 (human)
RGD
PMID:28298239
RGD:38549360
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Nlrp1a
NLR family, pyrin domain containing 1A
ISO
ClinVar Annotator: match by term: Respiratory papillomatosis, juvenile recurrent, congenital
ClinVar OMIM
PMID:17377159 PMID:24033266 PMID:25741868 PMID:28492532 PMID:31484767
NCBI chr10:55,778,560...55,833,639
Ensembl chr10:55,778,560...55,825,180
G
Pdcd1
programmed cell death 1
ISO
RGD
PMID:22322668
RGD:40822813
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
RT1-Bb
RT1 class II, locus Bb
severity
ISO
DNA:polymorphisms:cds:HLA-DQB1*0201, HLA-DQB1*0602 (human) DNA:polymorphism: :HLA-DQB1*0602(human)
RGD
PMID:15336778 PMID:19861144
RGD:5147657 , RGD:36174013
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
severity
ISO
DNA:polymorphisms:cds:HLA-DRB1*0301, HLA-DRB1*0102 (human)
RGD
PMID:15336778
RGD:5147657
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Tap1
transporter 1, ATP binding cassette subfamily B member
severity
ISO
DNA:polymorphism:cds:p.D637G(human)
RGD
PMID:14976605
RGD:5147844
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
ISO
ClinVar Annotator: match by term: Respiratory infections, recurrent, and failure to thrive with or without diarrhea
OMIM ClinVar
PMID:25741868 PMID:34952832
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Adam33
ADAM metallopeptidase domain 33
susceptibility
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:18778489 PMID:15298558
RGD:4145378 , RGD:4145383
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
G
Ang
angiogenin
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr15:24,312,711...24,323,361
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:12165532
RGD:5129220
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
ISO
RGD
PMID:1890650 PMID:11149999
RGD:4891044 , RGD:4891033
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Bdnf
brain-derived neurotrophic factor
susceptibility
IEP ISO
mRNA:increased expression:nasal cavity epithelium DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human)
RGD
PMID:20464992 PMID:21723144
RGD:4891116 , RGD:8655967
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
C3
complement C3
ISO IEP
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:20109314 PMID:17345707
RGD:5129539 , RGD:5129524
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C3ar1
complement C3a receptor 1
severity
ISO
protein:increased expression:nasal cavity
RGD
PMID:18538384
RGD:5129559
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
C5ar1
complement C5a receptor 1
ISO
RGD
PMID:18538384
RGD:5129559
NCBI chr 1:76,948,622...76,959,826
G
Casp1
caspase 1
ISO
protein:increased expression:serum
RGD
PMID:12396474 PMID:20974310
RGD:5130192 , RGD:5130187
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Cat
catalase
treatment
ISO
protein:increased activity:blood,nasal cavity mucosa:
RGD
PMID:21541033
RGD:9479054
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl1
C-C motif chemokine ligand 1
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17982926
RGD:4145109
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccl11
C-C motif chemokine ligand 11
severity
ISO IEP
associated with Sinusitis;protein:increased expression:paranasal sinus protein:increased expression:nasal mucus mRNA:increased expression:lung, nose
RGD
PMID:17999785 PMID:16120080 PMID:16765544
RGD:4145455 , RGD:4145411 , RGD:4145462
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl17
C-C motif chemokine ligand 17
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl19
C-C motif chemokine ligand 19
ISO
RGD
PMID:17947663
RGD:5130909
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl22
C-C motif chemokine ligand 22
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl24
C-C motif chemokine ligand 24
ISO
mRNA:increased expression:nasal cavity epithelium DNA:SNPs: :179T>C, 275C>T (human)
RGD
PMID:17982926 PMID:15580493
RGD:4145109 , RGD:4891493
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl26
C-C motif chemokine ligand 26
ISO
DNA:polymorphism: :2497T>G (human) associated with Eosinophilia;protein:increased expression:oronasal secretion (human)
RGD
PMID:15580493 PMID:24989688
RGD:4891493 , RGD:11531119
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:19786211
RGD:5130914
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl7
C-C motif chemokine ligand 7
ISO
RGD
PMID:17982926
RGD:4145109
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccr2
C-C motif chemokine receptor 2
susceptibility
ISO
Rhinitis, Allergic, Seasonal; DNA:SNP:cds:p.V64I (human)
RGD
PMID:17135764
RGD:4145111
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
ISO IEP
DNA:SNP:exon:51T>C (human) protein:increased expression:blood, T cell mRNA:increased expression:nose
RGD
PMID:17135764 PMID:17156343 PMID:20696593
RGD:4145111 , RGD:4145645 , RGD:4145454
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Cd14
CD14 molecule
susceptibility resistance
ISO
DNA:polymorphism:promoter:c. -159c>T (human)
RGD
PMID:20109306 PMID:16950285
RGD:4144795 , RGD:4144810
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd28
Cd28 molecule
ISO
RGD
PMID:21356099
RGD:5131612
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd80
Cd80 molecule
ISO
RGD
PMID:21108691
RGD:5132622
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cdc42
cell division cycle 42
ISO
mRNA:increased expression:nasal turbinate
RGD
PMID:19432938
RGD:5688273
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cftr
CF transmembrane conductance regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16083808
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Crhr2
corticotropin releasing hormone receptor 2
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr 4:84,222,897...84,265,924
Ensembl chr 4:84,224,002...84,265,904
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
protein:increased expression:T cell
RGD
PMID:17625281
RGD:4891512
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:plasma
RGD
PMID:14657873
RGD:4891906
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
protein:increased expression:nasal mucus
RGD
PMID:20659080
RGD:4892030
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
DNA:SNP:3' utr:*1934G>A (human)
RGD
PMID:20088379
RGD:5143945
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17627772 PMID:16689996 PMID:15379985 PMID:18946234
RGD:4781451 , RGD:4783198 , RGD:4847512 , RGD:4888516
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Cysltr2
cysteinyl leukotriene receptor 2
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:16689996
RGD:4783198
NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136
G
Fcer1a
Fc epsilon receptor Ia
ISO
RGD
PMID:20650300
RGD:5128714
NCBI chr13:85,686,099...85,692,394
Ensembl chr13:85,686,092...85,692,351
G
Fis1
fission, mitochondrial 1
IEP
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
G
Hdc
histidine decarboxylase
ISO IEP
DNA:SNP: :p.E644D (rs2073440) (human)
RGD
PMID:20608921 PMID:15054596
RGD:5128884 , RGD:5143921
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hnmt
histamine N-methyltransferase
no_association
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17651147 PMID:17651147
RGD:5128885
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Hrh1
histamine receptor H 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
G
Il13
interleukin 13
susceptibility disease_progression
ISO IEP
associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human) mRNA:increased expression:nose DNA:polymorphism: :rs1800925 (human)
RGD
PMID:16120094 PMID:20358028 PMID:20696593 PMID:17088137 PMID:20484924
RGD:4206706 , RGD:4145767 , RGD:4145454 , RGD:4159171 , RGD:4145534
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:17088137
RGD:4159171
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il15
interleukin 15
ISO
RGD
PMID:16750998
RGD:5000756
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il16
interleukin 16
ISO
protein:increased expression:serum protein:increased expression:nasal cavity epithelium, serum
RGD
PMID:18254318 PMID:19295235
RGD:5024932 , RGD:5024931
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
G
Il17a
interleukin 17A
ISO
protein:increased expression:nasal mucosa
RGD
PMID:20506642 PMID:19927541
RGD:4889137 , RGD:4889144
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
disease_progression
ISO
protein:increased expression:nasal lavage fluid, bronchoalveolar lavage fluid rhinitis allergic, seasonal; protein:increased expression:plasma protein:increased expression:serum
RGD
PMID:17305282 PMID:15934281 PMID:17323858
RGD:4889917 , RGD:4889927 , RGD:4889916
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
susceptibility
IEP ISO
mRNA:increased expression:nasal cavity epithelium associated with Hypersensitivity;DNA:polymorphism: :-511C>T (human) associated with Hypersensitivity;protein:increased expression:nasal mucus
RGD
PMID:20490816 PMID:14533660 PMID:10224452
RGD:4142821 , RGD:4142859 , RGD:4143227
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
severity
ISO
associated with Sinusitis;DNA:SNPs: :multiple (human)
RGD
PMID:19671251
RGD:5144228
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
associated with Hypersensitivity;DNA:repeat:intron (human)
RGD
PMID:14533660 PMID:15178892 PMID:10224452
RGD:4142859 , RGD:4143215 , RGD:4143227
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
susceptibility
ISO
DNA:SNP:promoter:rs2069762(human)
RGD
PMID:16333313
RGD:8663473
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il21
interleukin 21
ISO
RGD
PMID:17982108
RGD:5147397
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il22
interleukin 22
severity
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:21535180
RGD:5147409
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Il23r
interleukin 23 receptor
susceptibility
ISO
DNA:SNP,haplotype: :rs7517847(human)
RGD
PMID:23696856
RGD:8549605
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Il27ra
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:19354069
RGD:5128480
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
G
Il4
interleukin 4
ISO IEP
mRNA:increased expression:nasal cavity epithelium CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:19672097 PMID:21208219 PMID:18826099
RGD:5128558 , RGD:2317285
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
ISO
DNA:polymorphism: :c.1432T>C (human)
RGD
PMID:15564773
RGD:4890394
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il5
interleukin 5
ISO
RGD
PMID:11884474
RGD:5128622
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il9
interleukin 9
ISO
RGD
PMID:20525149
RGD:5128687
NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895
G
Lep
leptin
ISO
RGD
PMID:19860581
RGD:5128850
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:18831943
RGD:8693717
NCBI chr 1:228,016,439...228,024,736
G
Mfn1
mitofusin 1
IEP
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
G
Mif
macrophage migration inhibitory factor
severity
ISO
protein:increased expression:serum, nasal mucosa
RGD
PMID:15053202 PMID:15922619
RGD:4891045 , RGD:4891056
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Ms4a2
membrane spanning 4-domains A2
ISO
RGD
PMID:15480314
RGD:5131152
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
IEP ISO
mRNA:increased expression:nose
RGD
PMID:20696593 PMID:15715404
RGD:4145454 , RGD:7364740
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Ngf
nerve growth factor
ISO
protein:increased expression:respiratory system fluid/secretion associated with Sinusitis;protein:increased expression:respiratory system mucosa
RGD
PMID:10224365 PMID:19958603
RGD:4891115 , RGD:4891064
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:blood, eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nod1
nucleotide-binding oligomerization domain containing 1
ISO
mRNA:decreased expression:nose
RGD
PMID:20384614
RGD:5131446
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:cds:2104C>T,2722G>C (human)
RGD
PMID:12704363
RGD:5131484
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:18254476
RGD:4891910
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
protein:increased expression:eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Opa1
OPA1, mitochondrial dynamin like GTPase
IEP
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Plau
plasminogen activator, urokinase
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:21339035
RGD:8547809
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Ptgdr2
prostaglandin D2 receptor 2
ISO
RGD
PMID:19230460 PMID:19608418
RGD:5135021 , RGD:5135017
NCBI chr 1:207,585,088...207,590,275
Ensembl chr 1:207,587,917...207,589,213
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DQA1*0201, HLA-DQA1*0302 (human)
RGD
PMID:14990915
RGD:5147798
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*0602 (human)
RGD
PMID:14990915
RGD:5147798
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Scgb3a2
secretoglobin, family 3A, member 2
ISO
protein:increased expression:sputum mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:17218572 PMID:21385388
RGD:5144232 , RGD:5147389
NCBI chr18:35,932,840...35,935,762
Ensembl chr18:35,932,840...35,935,762
G
Serpine1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:19063817
RGD:4144832
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sftpd
surfactant protein D
susceptibility
ISO
associated with Hypersensitivity;DNA:polymorphism: :p.M11T (human)
RGD
PMID:19493231
RGD:4143494
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Tap1
transporter 1, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:SNPs: :
RGD
PMID:17982230 PMID:12018331
RGD:6482262 , RGD:6482274
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tbxa2r
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Tgfb1
transforming growth factor, beta 1
ISO
associated with Sinusitis
RGD
PMID:18423831
RGD:4145277
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
susceptibility no_association
ISO
DNA:SNPs: :597T>C, 1350T>C (human) mRNA:decreased expression:nasal mucosa: associated with Sinusitis;DNA:SNPs: :multiple (human)
RGD
PMID:19763595 PMID:18219831 PMID:19128592
RGD:4145354 , RGD:7800742 , RGD:4145356
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr6
toll-like receptor 6
ISO
associated with Asthma;DNA:SNP: :rs2381289 (human)
RGD
PMID:20815312
RGD:4145352
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
G
Tnf
tumor necrosis factor
ISO IEP
mRNA:increased expression:nose
RGD
PMID:15120189 PMID:20696593
RGD:4143470 , RGD:4145454
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vip
vasoactive intestinal peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121 PMID:14680090
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:haplotype: :
RGD
PMID:17321882
RGD:8547664
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:haplotype: :
RGD
PMID:17321882
RGD:8547664
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Anxa1
annexin A1
ISO
associated with Nasal Polyps
RGD
PMID:22279949
RGD:7421555
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
C3
complement C3
ISO
protein:increased expression:serum
RGD
PMID:19593977
RGD:4889484
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C4a
complement C4A
disease_progression
ISO
DNA:deletion: :
RGD
PMID:16879240
RGD:5688262
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
G
Ccl20
C-C motif chemokine ligand 20
ISO
RGD
PMID:16702571
RGD:7483585
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Hgf
hepatocyte growth factor
susceptibility
ISO
DNA:haplotype::rs38850,rs38855,rs38857(human)
RGD
PMID:20416453
RGD:8548615
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Igf1
insulin-like growth factor 1
ISO
mRNA:increased expression:nose:
RGD
PMID:20713758
RGD:8548883
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
ISO
protein:decreased expression:blood, mononuclear cell
RGD
PMID:23168151
RGD:7364820
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
ISO
associated with Asthma;mRNA, protein:increased expression:nasal polyps (human)
RGD
PMID:19672092
RGD:4889146
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112
RGD:7401169
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il22ra1
interleukin 22 receptor subunit alpha 1
susceptibility
ISO
DNA:SNPs:5' utr, intron: (rs4292900, rs16829225, rs4648936) (human)
RGD
PMID:19393422
RGD:5147411
NCBI chr 5:147,961,496...147,986,296
Ensembl chr 5:147,961,349...147,986,296
G
Il4
interleukin 4
treatment
ISO
associated with Asthma
RGD
PMID:12787306
RGD:7829803
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:23401274
RGD:8547880
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
treatment
IDA
RGD
PMID:23131200 PMID:19389874
RGD:7349403 , RGD:7364734
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Prkra
protein activator of interferon induced protein kinase EIF2AK2
severity
ISO
associated with Nasal Polyps
RGD
PMID:22961479
RGD:7777146
NCBI chr 3:61,575,447...61,594,393
Ensembl chr 3:61,575,447...61,594,347
G
Serpine1
serpin family E member 1
ISO
protein:increased expression:nasal mucosa (human)
RGD
PMID:21711960
RGD:6483796
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Tlr2
toll-like receptor 2
susceptibility
ISO
mRNA,protein:increased expression:paranasal sinus DNA:polymorphisms:: rs3804099,rs3804100(human)
RGD
PMID:22182736 PMID:21493395
RGD:7800733 , RGD:8552975
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
mRNA,protein:increased expression:paranasal sinus
RGD
PMID:22182736
RGD:7800733
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112 PMID:20147558
RGD:7401169 , RGD:7401236
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphisms, haplotypes:cds:HLA-DQB1*0301, HLA-DQB1*0302 (human)
RGD
PMID:15577839
RGD:5147654
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Alox5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:16677242
RGD:5147463
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Apoa4
apolipoprotein A4
resistance
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20810159
RGD:5685642
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Bdnf
brain-derived neurotrophic factor
severity
ISO
protein:increased expression:blood, nasal cavity epithelium
RGD
PMID:18266897
RGD:5144117
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:inferior turbinate, epithelium (human)
RGD
PMID:20459697
RGD:4891379
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cma1
chymase 1
ISO
protein:increased expression:nasal mucosa, mast cell (human)
RGD
PMID:11549546
RGD:5128839
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
G
Fga
fibrinogen alpha chain
ISO
RGD
PMID:21887273
RGD:5688767
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Gsto1
glutathione S-transferase omega 1
ISO
protein:decreased expression;T lymphocyte:
RGD
PMID:21410266
RGD:5491008
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased secretion:nasopharynx, secretion (human)
RGD
PMID:20128420
RGD:4145459
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifngr1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:19505388
RGD:7365025
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
susceptibility no_association
ISO
DNA:SNPs:promoters, exon:multiple DNA:SNPs:promoters:multiple
RGD
PMID:12532106 PMID:12532106
RGD:8655871 , RGD:8655871
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il4
interleukin 4
ISO
protein:increased expression:serum mRNA:increased expression:nose:
RGD
PMID:9237816 PMID:7551298
RGD:7829817 , RGD:8662960
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:nasal cavity of mucosa:
RGD
PMID:17651148
RGD:8551771
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Mc1r
melanocortin 1 receptor
no_association
ISO
RGD
PMID:20357480
RGD:5687317
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mmp9
matrix metallopeptidase 9
ISO
DNA:SNPs:promoter, intron, cds:-1590C>T, 2127G>T, p.R668Q (rs3918242, rs2274755, rs17577) (human)
RGD
PMID:22237587
RGD:8547819
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nod1
nucleotide-binding oligomerization domain containing 1
susceptibility
ISO
DNA:SNP: :rs2075817 (human)
RGD
PMID:16918516
RGD:5131519
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:5'UTR/exon, exon:rs5743266, rs2066842 (human)
RGD
PMID:16008671
RGD:5131477
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*05 (human) DNA:polymorphisms, haplotype:cds:HLA-DQB1*0301, HLA-DQB1*0501 (human)
RGD
PMID:22032123 PMID:9641569
RGD:7421561 , RGD:7421576
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Scgb1a1
secretoglobin family 1A member 1
ISO
mRNA, protein:decreased expression:nasal lavage fluid
RGD
PMID:15836756
RGD:5144234
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
G
Tlr3
toll-like receptor 3
ISO
protein:decreased expression:bone marrow, blood, eosinophil (human)
RGD
PMID:19752565
RGD:5129130
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
susceptibility
ISO
DNA:polymorphisms:cds:p.D299G, T399I (human)
RGD
PMID:18517079
RGD:4144192
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Vegfa
vascular endothelial growth factor A
ISO
mRNA,protein:increased expression:nasal biopsies,nasal lavage fluid:
RGD
PMID:12633568
RGD:7483595
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
susceptibility
ISO
RGD
PMID:15784866
RGD:5128832
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15381116
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
treatment susceptibility severity
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:heart (mouse) human gene in a mouse model
CTD RGD
PMID:14647384 PMID:16007097 PMID:16166518 PMID:16339146 PMID:19453650 PMID:19625462 PMID:23678171 PMID:24172901 PMID:24227843 PMID:26801988 PMID:31996437 PMID:32092392 PMID:32201080 PMID:19453650 PMID:32553273 PMID:17974127 PMID:16007097 More...
RGD:40818405 , RGD:32716426 , RGD:30309965 , RGD:30309202
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Anpep
alanyl aminopeptidase, membrane
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Bpi
bactericidal/permeability-increasing protein
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 3:146,909,626...146,936,487
Ensembl chr 3:146,909,629...146,936,221
G
C1qb
complement C1q B chain
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
C5ar1
complement C5a receptor 1
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 1:76,948,622...76,959,826
G
Casp3
caspase 3
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl1
C-C motif chemokine ligand 1
ISO
mRNA: increased expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccl2
C-C motif chemokine ligand 2
treatment severity
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:bronchoalveolar lavage (human) protein:increased expression:serum (human) mRNA, protein: increased expression, altered expression:lung (mouse) protein:increased expression:plasma (human)
CTD RGD
PMID:20484496 PMID:15888207 PMID:32553273 PMID:15602737 PMID:15356152 PMID:15781938 PMID:15657466 PMID:16195357 More...
RGD:34201108 , RGD:32716426 , RGD:32716399 , RGD:30309221 , RGD:30309220 , RGD:30309219 , RGD:30309218
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
ISO
mRNA, protein: increased expression, altered expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
severity treatment
ISO
Severe Acute Respiratory Syndrome; DNA:transversion:5' utr:-28C>G (human) protein:increased expression:bronchoalveolar lavage (human) mRNA, protein: increased expression, altered expression:lung, brain (mouse) protein:increased expression:plasma (human) mRNA:increased expression:lung (mouse)
RGD
PMID:19258635 PMID:15888207 PMID:15865221 PMID:32553273 PMID:15356152 PMID:15781938 PMID:16195357 PMID:32365944 More...
RGD:4891448 , RGD:34201108 , RGD:33769580 , RGD:32716426 , RGD:30309221 , RGD:30309220 , RGD:30309218 , RGD:30309207
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr1
C-C motif chemokine receptor 1
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr 8:123,556,286...123,561,841
G
Ccr3
C-C motif chemokine receptor 3
ISO
mRNA:altered expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Cd14
CD14 molecule
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd3e
CD3 epsilon subunit of T-cell receptor complex
ISO
protein:increased expression:Tcell, testis (human)
RGD
PMID:16237152
RGD:27372876
NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
G
Cd4
Cd4 molecule
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 4:157,668,878...157,695,366
G
Cd68
Cd68 molecule
disease_progression
ISO
mRNA, protein:increased expression:lung (human) protein:increased expression:macrophage, testis (human)
RGD
PMID:19635508 PMID:16237152
RGD:5490168 , RGD:27372876
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd9
CD9 molecule
disease_progression
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Clcf1
cardiotrophin-like cytokine factor 1
disease_progression
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
G
Clec4m
C-type lectin domain family 4 member M
susceptibility no_association
ISO
DNA:repeats:exon 4:
RGD
PMID:16369534 PMID:18708672 PMID:17534355 PMID:17534354
RGD:35673327 , RGD:36049808 , RGD:36049807 , RGD:36049806
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
G
Ctsl
cathepsin L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16081529 PMID:16339146 PMID:22496216 PMID:23678171
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19741068
RGD:4143520
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
treatment severity disease_progression
ISO
protein:increased expression:serum protein:increased expression:serum (human) mRNA, protein: increased expression, altered expression:lung (mouse) mRNA, protein:increased expression:serum, lung (human) mRNA, protein:increased expression:plasma, lung (human) protein:increased expression:lung (human) protein:increased expression:lung (mouse) mRNA:increased expression:lung (mouse) mRNA:decreased expression:lung (human)
RGD
PMID:17052299 PMID:15865221 PMID:32553273 PMID:15602737 PMID:15356152 PMID:15781938 PMID:15657466 PMID:16195357 PMID:17129463 PMID:20231782 PMID:32365944 PMID:19635508 More...
RGD:5135440 , RGD:33769580 , RGD:32716426 , RGD:32716399 , RGD:30309221 , RGD:30309220 , RGD:30309219 , RGD:30309218 , RGD:30309217 , RGD:30309216 , RGD:30309207 , RGD:5490168
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
treatment
ISO
RGD
PMID:32553273
RGD:32716426
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
mRNA:altered expression:lung (mouse)
RGD
PMID:32364527
RGD:27226699
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
IEP
protein:increased expression:respiratory fluid/secretion
RGD
PMID:19741068
RGD:4143520
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
severity treatment
ISO
mRNA, protein:increased expression:lung protein:increased expression:bronchoalveolar lavage (human) protein:increased expression:plasma (human) protein:increased expression:serum (human) mRNA, protein: increased expression, altered expression:lung (mouse)
RGD
PMID:19906920 PMID:15888207 PMID:16195357 PMID:15602737 PMID:15356152 PMID:15781938 More...
RGD:4891446 , RGD:34201108 , RGD:30309218 , RGD:32716399 , RGD:30309221 , RGD:30309220
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
mRNA:altered expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Egfr
epidermal growth factor receptor
severity
ISO
RGD
PMID:28404843
RGD:38599178
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Fgb
fibrinogen beta chain
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgf7
fibroblast growth factor 7
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Fgg
fibrinogen gamma chain
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Fn1
fibronectin 1
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fshb
follicle stimulating hormone subunit beta
ISO
protein:increased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Gh1
growth hormone 1
ISO
protein:decreased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Hp
haptoglobin
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Ifna1
interferon, alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15200845
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
G
Ifnb1
interferon beta 1
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15200845 PMID:26861016 PMID:32553273
RGD:32716426
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ifng
interferon gamma
susceptibility treatment
ISO
DNA:polymorphism:cds:+874A>T(human) protein:increased expression:peripheral blood mononuclear cells (human) protein:increased expression:serum (human) DNA:SNP:intron:+874A>T (rs2430561)(human)
RGD
PMID:19258635 PMID:15865221 PMID:16781892 PMID:15602737 PMID:16672072 PMID:19526193 PMID:17872527 More...
RGD:4891448 , RGD:33769580 , RGD:32716400 , RGD:32716399 , RGD:32716398 , RGD:32716397 , RGD:32716396
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
treatment
IEP ISO
protein:increased expression:serum, bronchoalveolar Lavage fluid (rat)
RGD
PMID:16409721 PMID:15865221
RGD:32726073 , RGD:33769580
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
ISO
protein:increased expression:serum (human)
RGD
PMID:15602737
RGD:32716399
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
mRNA:altered expression:lung (mouse)
RGD
PMID:32364527
RGD:27226699
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
severity
ISO
mRNA:altered expression:lung (mouse) mRNA, protein:increased expression:lung, bronchoalveolar lavage (mouse)
RGD
PMID:32364527 PMID:32365944
RGD:27226699 , RGD:30309207
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il23a
interleukin 23 subunit alpha
ISO
mRNA:decreased expression:lung (mouse)
RGD
PMID:32364527
RGD:27226699
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il6
interleukin 6
severity disease_progression treatment
ISO IEP
protein:increased expression:serum (human) protein:increased expression:blood (human) protein:increased expression:bronchoalveolar lavage (human) protein:increased expression:serum, Bronchoalveolar Lavage fluid (rat)
RGD
PMID:15657466 PMID:15472864 PMID:15888207 PMID:15865221 PMID:16409721 PMID:32553273 PMID:15271897 More...
RGD:30309219 , RGD:34888224 , RGD:34201108 , RGD:33769580 , RGD:32726073 , RGD:32716426 , RGD:32716401
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7
interleukin 7
ISO
mRNA:decreased expression:lung (mouse)
RGD
PMID:32364527
RGD:27226699
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
G
Irf3
interferon regulatory factor 3
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (human)
CTD RGD
PMID:26861016 PMID:19635508
RGD:5490168
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
G
Itga2b
integrin subunit alpha 2b
disease_progression
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
G
Krt7
keratin 7
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Lhb
luteinizing hormone subunit beta
ISO
protein:increased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20484496
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20484496
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Msr1
macrophage scavenger receptor 1
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676
G
Myd88
MYD88, innate immune signal transduction adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nfil3
nuclear factor, interleukin 3 regulated
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
RGD
PMID:32365944
RGD:30309207
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Pecam1
platelet and endothelial cell adhesion molecule 1
disease_progression
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pi4kb
phosphatidylinositol 4-kinase beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253445
NCBI chr 2:182,540,377...182,572,684
Ensembl chr 2:182,540,567...182,588,488
G
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:plasma (human)
RGD
PMID:16274108
RGD:30309949
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plg
plasminogen
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
G
Pomc
proopiomelanocortin
ISO
protein:decreased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Prl
prolactin
ISO
protein:increased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Rab31
RAB31, member RAS oncogene family
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
RT1-Da
RT1 class II, locus Da
disease_progression
ISO
mRNA:increased expression:lung
RGD
PMID:19635508
RGD:5490168
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
G
RT1-Db1
RT1 class II, locus Db1
ISO
DNA:polymorphism:cds:HLA-DRB1*0301 (human) DNA:polymorphism:cds:HLA-DRB1*12 (human)
RGD
PMID:15243926 PMID:19445991
RGD:32716374 RGD:32716381
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
S100a8
S100 calcium binding protein A8
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
ISO
protein:increased expression:plasma
RGD
PMID:16649161
RGD:5147434
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Slpi
secretory leukocyte peptidase inhibitor
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Stat1
signal transducer and activator of transcription 1
ISS
MouseDO
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Tbk1
TANK-binding kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr 7:57,077,830...57,110,868
Ensembl chr 7:57,077,830...57,110,892
G
Tgfb1
transforming growth factor, beta 1
ISO IEP
protein:increased expression:serum (human) protein:increased expression:serum, bronchoalveolar Lavage fluid (rat)
RGD
PMID:15271897 PMID:16409721
RGD:32716401 , RGD:32726073
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Thbd
thrombomodulin
ISO
protein:increased expression:plasma (human)
RGD
PMID:16274108
RGD:30309949
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Ticam2
TIR domain containing adaptor molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
G
Tirap
TIR domain containing adaptor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26861016
NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
G
Tlr2
toll-like receptor 2
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:19635508
RGD:5490168
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tmprss11d
transmembrane serine protease 11D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24227843
NCBI chr14:21,707,336...21,769,398
Ensembl chr14:21,707,336...21,769,396
G
Tmprss2
transmembrane serine protease 2
severity
ISO
RGD
PMID:30626688
RGD:30309210
NCBI chr11:36,934,306...36,973,779
Ensembl chr11:36,934,306...36,973,715
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:plasma (human) protein:increased expression:bronchoalveolar lavage (human)
RGD
PMID:14514395 PMID:15888207
RGD:30309961 , RGD:34201108
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tshb
thyroid stimulating hormone subunit beta
ISO
protein:decreased expression:adenohypophysis (human)
RGD
PMID:20651845
RGD:28711759
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26801988
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vwf
von Willebrand factor
ISO
protein:increased expression:lung (mouse)
RGD
PMID:23919993
RGD:30310231
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Xcl1
X-C motif chemokine ligand 1
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:15356152
RGD:30309221
NCBI chr13:77,248,687...77,252,343
Ensembl chr13:77,248,717...77,252,329
G
Sting1
stimulator of interferon response cGAMP interactor 1
severity
ISO
RGD
PMID:31141689
RGD:39128194
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:19786211
RGD:5130914
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Cfb
complement factor B
ISO
protein:decreased expression:serum
RGD
PMID:14510109
RGD:7411729
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cftr
CF transmembrane conductance regulator
susceptibility
ISO
DNA:mutations: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16083808 PMID:11773581
RGD:4140477
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Chia
chitinase, acidic
severity
ISO
mRNA:decreased expression:sinus, epithelial cell (human)
RGD
PMID:19379605
RGD:5037227
NCBI chr 2:193,614,374...193,656,532
Ensembl chr 2:193,614,114...193,656,533
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
associated with Rhinitis;mRNA:increased expression:paranasal sinus
RGD
PMID:19153309
RGD:5135257
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Il13
interleukin 13
susceptibility
ISO
associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20358028 PMID:20358028
RGD:4145767
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il1b
interleukin 1 beta
ISO
associated with Hypersensitivity
RGD
PMID:16358839
RGD:4143214
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
ISO
RGD
PMID:11758471
RGD:8662964
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Lta
lymphotoxin alpha
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:11037831
RGD:4143260
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression::
RGD
PMID:20392482
RGD:5130763
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
ISO
protein:increased secretion:sinus mucus
RGD
PMID:17063754
RGD:5131192
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
RGD
PMID:18396779
RGD:4892328
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Pdgfb
platelet derived growth factor subunit B
ISO
protein: increased expression: nasal cavity epithelium
RGD
PMID:21255638
RGD:6483060
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pip
prolactin induced protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 4:70,787,627...70,791,921
Ensembl chr 4:70,787,627...70,791,921
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:21711960
RGD:6483796
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
ISO
RGD
PMID:21711960
RGD:6483796
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Ppp1r9b
protein phosphatase 1, regulatory subunit 9B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr10:79,938,055...79,954,085
Ensembl chr10:79,938,066...79,954,083
G
Scgb3a2
secretoglobin, family 3A, member 2
ISO
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:21385388
RGD:5147389
NCBI chr18:35,932,840...35,935,762
Ensembl chr18:35,932,840...35,935,762
G
Sftpa1
surfactant protein A1
ISO
associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:17599561
RGD:4143506
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpd
surfactant protein D
ISO
associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:17599561
RGD:4143506
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
G
Tlr2
toll-like receptor 2
ISO
mRNA:increased expression:nasal cavity epithelium:
RGD
PMID:14743629
RGD:8552991
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
associated with Pneumococal Infections; mRNA:increased expression:nasal cavity epithelium:
RGD
PMID:16301373 PMID:14743629
RGD:7800729 , RGD:8552991
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr9
toll-like receptor 9
ISO
Chronic Sinusitis; protein:decreased expression:nasal mucosa, epithelial cell (human) Acute Sinusitis; protein:decreased expression:nasal mucosa, epithelial cell (human)
RGD
PMID:17283572 PMID:18416964
RGD:5130870 , RGD:5130708
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:23613163
RGD:38676477
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Cd86
CD86 molecule
ISO
protein:decreased expression:spleen, plasmacytoid dendritic cell (mouse)
RGD
PMID:20949109
RGD:4892562
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cftr
CF transmembrane conductance regulator
ISO
RGD
PMID:28289144
RGD:36049750
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:10228098
RGD:11039478
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Fn1
fibronectin 1
IDA
RGD
PMID:12065530
RGD:7205474
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Ifnar1
interferon alpha and beta receptor subunit 1
susceptibility
ISO
RGD
PMID:19603548 PMID:19603548
RGD:5490273 , RGD:5490273
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
G
Il10
interleukin 10
ISO
mRNA, protein:increased expression:lung
RGD
PMID:22940620
RGD:7364825
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il15
interleukin 15
ISO
RGD
PMID:18390740
RGD:4996474
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:20065029
RGD:4142828
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il33
interleukin 33
ISO
mRNA:increased expression:lung:
RGD
PMID:28401938
RGD:40400699
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
RGD
PMID:20493961
RGD:5131444
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:lung (mouse)
RGD
PMID:28663335
RGD:13432209
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
severity
ISO
mRNA:increased expression:lung associated with influenza
RGD
PMID:31782850 PMID:31782850
RGD:39131288 , RGD:39131288
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ripk3
receptor-interacting serine-threonine kinase 3
treatment
ISO
RGD
PMID:25445964
RGD:127229910
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Sftpb
surfactant protein B
ameliorates
ISO
RGD
PMID:20007532
RGD:151667448
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Atm
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:27421701
RGD:126779562
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Btk
Bruton tyrosine kinase
ISO
RGD
PMID:30873567
RGD:124715473
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
G
Clec4m
C-type lectin domain family 4 member M
severity
ISO
RGD
PMID:16134084
RGD:39938986
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
G
Ido1
indoleamine 2,3-dioxygenase 1
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:20385761
RGD:39938865
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
G
Ifng
interferon gamma
ISO
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il6
interleukin 6
ISO
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irak3
interleukin-1 receptor-associated kinase 3
severity
ISO
RGD
PMID:22492852
RGD:35316076
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Itgb2
integrin subunit beta 2
susceptibility
ISO
RGD
PMID:11390487
RGD:127345090
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Lamp1
lysosomal-associated membrane protein 1
ISO
protein:increased expression:lung, natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
G
Marco
macrophage receptor with collagenous structure
exacerbates
ISO
RGD
PMID:15263032
RGD:41412189
NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
G
Ncr1
natural cytotoxicity triggering receptor 1
severity
ISO
RGD
PMID:21887255
RGD:40818252
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
G
Pdcd1
programmed cell death 1
treatment
ISO
RGD
PMID:25624454
RGD:40818422
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
treatment
ISO
associated with immunodeficiency 14
RGD
PMID:30093657
RGD:40890269
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
severity
ISO
RGD
PMID:17322108
RGD:38599154
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Ripk3
receptor-interacting serine-threonine kinase 3
exacerbates
ISO
RGD
PMID:33625952
RGD:127229925
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:lung,natural killer cell (mouse)
RGD
PMID:21887255
RGD:40818252
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:16129701
RGD:8655932
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il5
interleukin 5
severity
ISO
RGD
PMID:9824515
RGD:11354934
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Igfbp3
insulin-like growth factor binding protein 3
treatment
ISO
RGD
PMID:27738609
RGD:12743605
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Adam33
ADAM metallopeptidase domain 33
susceptibility
ISO
DNA:SNP: :rs2787094 c.2891G>C (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
G
Bcl2
BCL2, apoptosis regulator
severity
ISO
protein:increased expression:natural killer cell, T cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
severity
ISO
protein:increased expression:natural killer cell,t cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
C3
complement C3
resistance
ISO
RGD
PMID:19258923 PMID:12235218
RGD:4142862 , RGD:5129513
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp1
caspase 1
ISO
RGD
PMID:15196254
RGD:5130189
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Cat
catalase
ISO
protein:decreased expression:nasal mucus
RGD
PMID:21471094
RGD:5130770
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl5
C-C motif chemokine ligand 5
susceptibility
ISO
protein:increased secretion:serum (human) DNA:snp:5' utr:g.-28C>G (human)
RGD
PMID:19005677 PMID:19099677
RGD:4891884 , RGD:4891881
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cd14
CD14 molecule
ISO
DNA:polymorphism:promoter:c.-550C>T (human)
RGD
PMID:17471431
RGD:4144210
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd274
CD274 molecule
treatment
ISO
mRNA:increased expression:lung
RGD
PMID:22797302 PMID:22797302
RGD:40818270 , RGD:40818270
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Csf2
colony stimulating factor 2
ISO
protein:increased expression:nasal mucus
RGD
PMID:20088864
RGD:4143440
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
DNA:SNP: :p.T280M (human)
RGD
PMID:18257903 PMID:16645504
RGD:4891891 , RGD:4891905
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl10
C-X-C motif chemokine ligand 10
IEP ISO
mRNA:increased expression:lung protein:increased expression:plasma
RGD
PMID:12909590 PMID:20561238
RGD:2311388 , RGD:5135493
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:20561238
RGD:5135493
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Fas
Fas cell surface death receptor
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Flt3
Fms related receptor tyrosine kinase 3
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Ifnl1
interferon, lambda 1
exacerbates
ISO
associated with respiratory syncytial virus infectious disease;mRNA:increased expression:mucosa of nasopharynx (human)
RGD
PMID:24389019
RGD:126848743
NCBI chr 1:83,798,651...83,800,297
Ensembl chr 1:83,798,703...83,800,235
G
Il15
interleukin 15
severity
ISO
mRNA,protein:increased expression:peripheral blood mononuclear cell,serum,dendritic cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17a
interleukin 17A
susceptibility
ISO
DNA:SNP: :rs7747909(human)
RGD
PMID:17703412
RGD:4889847
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:SNP: :c.390T>C (rs315952) (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il33
interleukin 33
ISO
protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4r
interleukin 4 receptor
susceptibility
ISO
associated with respiratory syncystial virus infection; DNA:polymorphism:cds:p. Q551R (human) DNA:SNPs: :rs1805011,rs2057768 (human)
RGD
PMID:12508140 PMID:20404812 PMID:17703412
RGD:4890022 , RGD:4889996 , RGD:4889847
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
ISO
mRNA, protein:increased expression:respiratory system fluid/secretion
RGD
PMID:14738241
RGD:5128668
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il9
interleukin 9
ISO
RGD
PMID:15051283
RGD:5128692
NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895
G
Jak3
Janus kinase 3
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Klrk1
killer cell lectin like receptor K1
susceptibility
ISO
DNA:SNP,haplotypes:3'utr: (rs10772271) (human)
RGD
PMID:29967528
RGD:39128159
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
G
Mpo
myeloperoxidase
ISO
RGD
PMID:7841728
RGD:5130995
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Muc1
mucin 1, cell surface associated
severity
ISO
protein:increased expression:serum
RGD
PMID:19856476
RGD:5131164
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Nfkb1
nuclear factor kappa B subunit 1
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
susceptibility
ISO
associated with respiratory syncytial virus infectious disease;DNA:SNP:promoter: (rs2233406) (human)
RGD
PMID:23487427
RGD:40902982
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
susceptibility
ISO
DNA:SNP: :rs1060826(human)
RGD
PMID:17703412
RGD:4889847
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Pdcd1
programmed cell death 1
ISO
protein:increased expression:CD8 T cell
RGD
PMID:22797302
RGD:40818270
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Postn
periostin
ISO
mRNA,protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Stat5a
signal transducer and activator of transcription 5A
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Tlr4
toll-like receptor 4
ISO
protein:increased expression:monocyte protein:decreased expression:neutrophil
RGD
PMID:14738455 PMID:19497921
RGD:4144819 , RGD:4144183
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr5
toll-like receptor 5
susceptibility
ISO
DNA:snp:cds:p.F616L rs5744174 (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
G
Tnf
tumor necrosis factor
susceptibility
ISO
DNA:SNP: :rs1799724(human) DNA:polymorphism:promoter: c. -308A>G (human) protein:increased expression:nasal lavage fluid
RGD
PMID:17703412 PMID:19849941 PMID:20088864
RGD:4889847 , RGD:4143441 , RGD:4143440
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tslp
thymic stromal lymphopoietin
severity
ISO
mRNA, protein:increased expression:nasal mucus (human)
RGD
PMID:28471975
RGD:38596342
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Vdr
vitamin D receptor
susceptibility
ISO
DNA:SNP (human) DNA:SNP: :rs10735810 (human)
RGD
PMID:18266602 PMID:17703412
RGD:4889843 , RGD:4889847
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15381116
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ccl11
C-C motif chemokine ligand 11
ISO
RGD
PMID:20644177
RGD:4140459
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
ISO
RGD
PMID:19617401
RGD:4891451
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
ISO
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:20957032
RGD:5130904
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccr1
C-C motif chemokine receptor 1
ISO
RGD
PMID:15254170
RGD:5688163
NCBI chr 8:123,556,286...123,561,841
G
Cd68
Cd68 molecule
ISO
mRNA:increased expression:lung,trachea (mouse)
RGD
PMID:12581500
RGD:40925942
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19671179
RGD:5134975
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:17655904
RGD:5135437
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl16
C-X-C motif chemokine ligand 16
ISO
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:19671179
RGD:5134975
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:17655904
RGD:5135437
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Fgf10
fibroblast growth factor 10
treatment
ISO
protein:increased expression:epithelial stem/progenitor cells (mouse)
RGD
PMID:27322618 PMID:27322618
RGD:127284849 , RGD:127284849
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
G
Fgfr2
fibroblast growth factor receptor 2
ISO
protein:increased expression:epithelial stem/progenitor cells (mouse)
RGD
PMID:27322618
RGD:127284849
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Hmox1
heme oxygenase 1
ISO
mRNA:increased expression:lung
RGD
PMID:8843786
RGD:4145417
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Ifnar1
interferon alpha and beta receptor subunit 1
disease_progression
ISO
H1N1 virus susceptibility
RGD
PMID:21383977 PMID:21383977
RGD:5490272 , RGD:5490272
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:25219125
RGD:10450576
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il15
interleukin 15
ISO
RGD
PMID:20335267
RGD:4892670
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17ra
interleukin 17 receptor A
ISO
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
G
Il1b
interleukin 1 beta
ISO
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
mRNA:increased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il4r
interleukin 4 receptor
ISO
mRNA:decreased expression:bronchoalveolar lavage (human)
RGD
PMID:32407669
RGD:30296672
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Mif
macrophage migration inhibitory factor
ISO
RGD
PMID:19941385
RGD:4891005
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Tlr9
toll-like receptor 9
ISO
DNA:snp:promoter:g.-1237T>C rs5743836 (human)
RGD
PMID:19539691
RGD:5130766
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
treatment
ISO
RGD
PMID:25219125
RGD:10450576
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Rpgr
retinitis pigmentosa GTPase regulator
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS, AND DEAFNESS | ClinVar Annotator: match by term: Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness
OMIM CTD ClinVar
PMID:1733835 PMID:8673101 PMID:10094550 PMID:14627685 PMID:16055928 PMID:25741868 More...
NCBI chr X:12,566,447...12,628,171
Ensembl chr X:12,566,645...12,747,882
G
Pgk1
phosphoglycerate kinase 1
ISO
ClinVar Annotator: match by term: Male infertility due to obstructive azoospermia
ClinVar
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all